| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD4 RGPD1 TSC2 ARHGAP22 SRGAP3 RGPD3 ARAP1 RGPD5 RGPD2 RANBP2 RGPD8 RASA1 ARHGAP23 SRGAP2 RALGAPA2 ARAP3 PLEKHG6 | 1.45e-07 | 279 | 258 | 17 | GO:0005096 |
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.46e-07 | 20 | 258 | 6 | GO:0061665 | |
| GeneOntologyMolecularFunction | calcium ion binding | CDHR1 FSTL5 FSTL4 CDH23 ADGRV1 PKD1L2 EFHB JAG1 SYT13 ADGRL3 NOTCH3 PCDHGB2 SGCA PCDHGA9 ESYT1 PCDHB8 CAPN11 MYOF CDH24 CELSR1 PLA2G4C NKD2 CELSR2 HMCN1 DLL3 DCHS1 REPS2 CDH4 PCDHGA8 | 1.47e-07 | 749 | 258 | 29 | GO:0005509 |
| GeneOntologyMolecularFunction | kinase activity | CERKL CRIM1 IP6K3 TRPM7 DAPK2 DAPK1 DAPK3 CDKL1 MAP3K4 NRP2 PRKD3 NUAK1 FAM20B FER TJP2 FGFR2 ALK HSPB8 MAP3K14 MAGI3 PIP5K1C MAP3K6 TESK1 CDK13 PAK3 MAP3K13 NEK11 | 2.34e-06 | 764 | 258 | 27 | GO:0016301 |
| GeneOntologyMolecularFunction | SUMO transferase activity | 6.18e-06 | 36 | 258 | 6 | GO:0019789 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 RGPD1 TSC2 ARHGAP22 RCC1L SRGAP3 RGPD3 ARAP1 RGPD5 RGPD2 RANBP2 IPO7 RGPD8 RASA1 ARHGAP23 ARHGEF18 SRGAP2 RALGAPA2 ARAP3 PLEKHG6 | 1.06e-05 | 507 | 258 | 20 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 RGPD1 TSC2 ARHGAP22 RCC1L SRGAP3 RGPD3 ARAP1 RGPD5 RGPD2 RANBP2 IPO7 RGPD8 RASA1 ARHGAP23 ARHGEF18 SRGAP2 RALGAPA2 ARAP3 PLEKHG6 | 1.06e-05 | 507 | 258 | 20 | GO:0030695 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CERKL CRIM1 IP6K3 TRPM7 DAPK2 DAPK1 DAPK3 CDKL1 MAP3K4 NRP2 PRKD3 NUAK1 FAM20B UGP2 FER TJP2 FGFR2 ALK HSPB8 POLG MAP3K14 MAGI3 PIP5K1C MAP3K6 TESK1 CDK13 PAK3 MAP3K13 NEK11 | 1.29e-05 | 938 | 258 | 29 | GO:0016772 |
| GeneOntologyMolecularFunction | enzyme activator activity | RGPD4 LGMN TIFAB RGPD1 TSC2 PPP1R15A ARHGAP22 SRGAP3 RGPD3 GNAS ALK ARAP1 RGPD5 RGPD2 RANBP2 RGPD8 RASA1 ARHGAP23 SRGAP2 RALGAPA2 ARAP3 PLEKHG6 MAP3K13 | 1.54e-05 | 656 | 258 | 23 | GO:0008047 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CRIM1 IP6K3 TRPM7 DAPK2 DAPK1 DAPK3 CDKL1 MAP3K4 NRP2 PRKD3 NUAK1 FAM20B FER FGFR2 ALK HSPB8 MAP3K14 PIP5K1C MAP3K6 TESK1 CDK13 PAK3 MAP3K13 NEK11 | 1.78e-05 | 709 | 258 | 24 | GO:0016773 |
| GeneOntologyMolecularFunction | protein kinase activity | CRIM1 TRPM7 DAPK2 DAPK1 DAPK3 CDKL1 MAP3K4 NRP2 PRKD3 NUAK1 FER FGFR2 ALK HSPB8 MAP3K14 MAP3K6 TESK1 CDK13 PAK3 MAP3K13 NEK11 | 3.75e-05 | 600 | 258 | 21 | GO:0004672 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 4.33e-05 | 50 | 258 | 6 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 6.06e-05 | 53 | 258 | 6 | GO:0016859 | |
| GeneOntologyMolecularFunction | GTPase binding | RGPD4 RGPD1 DAPK3 TSC2 RGPD3 RGPD2 RANBP2 DMXL2 IPO7 RGPD8 RASA1 SRGAP2 PQBP1 NOX1 PAK3 | 7.45e-05 | 360 | 258 | 15 | GO:0051020 |
| GeneOntologyMolecularFunction | protein serine kinase activity | TRPM7 DAPK2 DAPK1 DAPK3 CDKL1 MAP3K4 PRKD3 NUAK1 MAP3K14 MAP3K6 TESK1 CDK13 PAK3 MAP3K13 NEK11 | 8.18e-05 | 363 | 258 | 15 | GO:0106310 |
| GeneOntologyMolecularFunction | enzyme regulator activity | RGPD4 LGMN CRIM1 TIFAB RGPD1 TSC2 ADGRV1 PPP1R15A ZEB2 ARHGAP22 WASH6P RCC1L SRGAP3 RGPD3 C3 GNAS ALK ARAP1 RGPD5 MAPK8IP1 RGPD2 RANBP2 IPO7 RGPD8 RASA1 ARHGAP23 ARHGEF18 SRGAP2 RALGAPA2 WASH3P FRY ARAP3 PLEKHG6 ELFN1 MAP3K13 | 1.69e-04 | 1418 | 258 | 35 | GO:0030234 |
| GeneOntologyMolecularFunction | adrenergic receptor binding | 2.36e-04 | 24 | 258 | 4 | GO:0031690 | |
| GeneOntologyMolecularFunction | beta-2 adrenergic receptor binding | 2.39e-04 | 10 | 258 | 3 | GO:0031698 | |
| GeneOntologyMolecularFunction | small GTPase binding | RGPD4 RGPD1 DAPK3 TSC2 RGPD3 RGPD2 RANBP2 DMXL2 IPO7 RGPD8 SRGAP2 NOX1 PAK3 | 2.95e-04 | 321 | 258 | 13 | GO:0031267 |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 3.78e-04 | 27 | 258 | 4 | GO:0004709 | |
| GeneOntologyMolecularFunction | structural constituent of synapse-associated extracellular matrix | 4.95e-04 | 3 | 258 | 2 | GO:0150043 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 5.48e-04 | 52 | 258 | 5 | GO:0035255 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 6.34e-04 | 81 | 258 | 6 | GO:0035254 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | TRPM7 DAPK2 DAPK1 DAPK3 CDKL1 MAP3K4 PRKD3 NUAK1 MAP3K14 MAP3K6 TESK1 CDK13 PAK3 MAP3K13 NEK11 | 7.35e-04 | 446 | 258 | 15 | GO:0004674 |
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 9.81e-04 | 4 | 258 | 2 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 9.81e-04 | 4 | 258 | 2 | GO:0047685 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 1.62e-03 | 5 | 258 | 2 | GO:0047894 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CEACAM5 ZBTB16 HLA-DQB1 LILRB2 CDHR1 CEACAM8 CDH23 CEACAM6 MDGA2 TSC2 ADGRV1 BCL6 ARID1A NLGN3 PTPRS JAG1 FER TJP2 DLG4 LRRC7 GNAS PLEKHA7 ADGRL3 PCDHGB2 PCDHGA9 PCDHB8 PIP5K1C CDH24 CELSR1 CELSR2 HMCN1 ARVCF ELFN1 DCHS1 KIRREL1 ROBO1 FUT7 CDH4 TNXB PCDHGA8 EP300 | 2.89e-10 | 1077 | 262 | 41 | GO:0098609 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 3.23e-10 | 9 | 262 | 6 | GO:0033133 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CEACAM5 CDHR1 CEACAM8 CDH23 CEACAM6 MDGA2 PTPRS ADGRL3 PCDHGB2 PCDHGA9 PCDHB8 CDH24 CELSR1 CELSR2 HMCN1 ARVCF ELFN1 DCHS1 ROBO1 CDH4 PCDHGA8 | 6.32e-10 | 313 | 262 | 21 | GO:0098742 |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 7.98e-10 | 10 | 262 | 6 | GO:1903301 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CEACAM5 CDHR1 CEACAM8 CDH23 CEACAM6 PCDHGB2 PCDHGA9 PCDHB8 CDH24 CELSR1 CELSR2 HMCN1 DCHS1 ROBO1 CDH4 PCDHGA8 | 2.32e-09 | 187 | 262 | 16 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell junction organization | LGMN CEACAM5 FRMPD4 LILRB2 HAPLN4 CEACAM6 DAPK3 MDGA2 TSC2 CSMD2 NRP2 NEDD4 NEDD9 ARHGAP22 NLGN3 PTPRS SRGAP3 ANAPC2 FER TJP2 C3 DLG4 FGFR2 PLEKHA7 ADGRL3 PCDHB8 LAMB2 SRGAP2 PIP5K1C CDH24 SHANK2 ELFN1 PAK3 KIRREL1 ROBO1 GRIP2 CDH4 | 2.53e-09 | 974 | 262 | 37 | GO:0034330 |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 3.32e-09 | 20 | 262 | 7 | GO:0006607 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 6.32e-09 | 13 | 262 | 6 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.09e-08 | 14 | 262 | 6 | GO:1903299 | |
| GeneOntologyBiologicalProcess | synapse organization | LGMN FRMPD4 LILRB2 HAPLN4 MDGA2 TSC2 CSMD2 NRP2 NEDD4 NEDD9 ARHGAP22 NLGN3 PTPRS SRGAP3 ANAPC2 C3 DLG4 FGFR2 ADGRL3 PCDHB8 LAMB2 SRGAP2 SHANK2 ELFN1 PAK3 ROBO1 GRIP2 | 2.08e-07 | 685 | 262 | 27 | GO:0050808 |
| GeneOntologyBiologicalProcess | protein import into nucleus | RGPD4 TRAF3IP2 RGPD1 TSC2 RGPD3 NPAP1 RGPD5 RGPD2 RANBP2 IPO7 RGPD8 TNFRSF1A EP300 | 1.35e-06 | 195 | 262 | 13 | GO:0006606 |
| GeneOntologyBiologicalProcess | neuron development | MYT1L MAP1A CDHR1 FSTL4 CDH23 TSC2 ADGRV1 PTCH1 ZEB2 NRP2 NEDD4 NLGN3 HOXD10 PTPRS ANAPC2 C3 DLG4 LRRC7 FGFR2 ALK NOTCH3 AGTPBP1 B4GAT1 NEUROD4 LAMB2 SPAG9 SRGAP2 PQBP1 PIP5K1C TDP2 FRY NOX1 NSMF CELSR2 PAK3 ROBO1 GRIP2 MAP3K13 CDH4 TNXB EP300 | 1.42e-06 | 1463 | 262 | 41 | GO:0048666 |
| GeneOntologyBiologicalProcess | import into nucleus | RGPD4 TRAF3IP2 RGPD1 TSC2 RGPD3 NPAP1 RGPD5 RGPD2 RANBP2 IPO7 RGPD8 TNFRSF1A EP300 | 1.89e-06 | 201 | 262 | 13 | GO:0051170 |
| GeneOntologyBiologicalProcess | regulation of kinase activity | RGPD4 SPRY1 CEACAM5 RGPD1 CEACAM6 TSC2 ZEB2 MAP3K4 NEDD9 RGPD3 DLG4 FGFR2 TAF7 ALK MAPK8IP1 RGPD2 RANBP2 IPO7 RGPD8 MAGI3 TESK1 SMG8 ROBO1 MAP3K13 TNXB | 2.48e-06 | 686 | 262 | 25 | GO:0043549 |
| GeneOntologyBiologicalProcess | regulation of synapse organization | FRMPD4 LILRB2 MDGA2 TSC2 NRP2 NEDD4 NEDD9 ARHGAP22 NLGN3 PTPRS SRGAP3 ANAPC2 DLG4 ADGRL3 SRGAP2 SHANK2 PAK3 ROBO1 | 2.52e-06 | 387 | 262 | 18 | GO:0050807 |
| GeneOntologyBiologicalProcess | postsynapse organization | LGMN FRMPD4 LILRB2 TSC2 CSMD2 NRP2 NEDD9 ARHGAP22 NLGN3 PTPRS SRGAP3 DLG4 ADGRL3 SHANK2 PAK3 GRIP2 | 2.77e-06 | 313 | 262 | 16 | GO:0099173 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | FRMPD4 LILRB2 MDGA2 TSC2 NRP2 NEDD4 NEDD9 ARHGAP22 NLGN3 PTPRS SRGAP3 ANAPC2 DLG4 ADGRL3 SRGAP2 SHANK2 PAK3 ROBO1 | 3.35e-06 | 395 | 262 | 18 | GO:0050803 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | SPRY1 CEACAM5 FSTL4 CEACAM6 DAPK3 TSC2 BCL6 PPP1R15A ZEB2 NEDD4 NLGN3 HOXC11 PTPRS JAG1 ANAPC2 MIEF1 C3 DLG4 FGFR2 ARAP1 RASA1 ARHGEF18 E2F2 SPAG9 PQBP1 CELSR1 NSMF PAK3 ROBO1 MAP3K13 TNFRSF1A CDH4 EP300 | 3.42e-06 | 1090 | 262 | 33 | GO:0022603 |
| GeneOntologyBiologicalProcess | cell morphogenesis | MAP1A CDHR1 FSTL4 CDH23 DAPK3 TSC2 BCL6 PTCH1 ZEB2 NRP2 NEDD4 NLGN3 PTPRS ANAPC2 DLG4 FGFR2 NOTCH3 ARAP1 B4GAT1 RASA1 LAMB2 ARHGEF18 SPAG9 SRGAP2 PQBP1 PIP5K1C FRY CDH24 NSMF CELSR2 PAK3 ROBO1 MAP3K13 CDH4 EP300 | 3.45e-06 | 1194 | 262 | 35 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | MAP1A CDHR1 FSTL4 CDH23 TSC2 PTCH1 ZEB2 NRP2 NEDD4 NLGN3 PTPRS ANAPC2 DLG4 FGFR2 NOTCH3 B4GAT1 LAMB2 PQBP1 PIP5K1C NSMF CELSR2 PAK3 ROBO1 MAP3K13 CDH4 EP300 | 3.65e-06 | 748 | 262 | 26 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | RGPD4 SPRY1 CEACAM5 MYOG LILRB2 RGPD1 CEACAM6 TSC2 PPP1R15A ZEB2 MAP3K4 NEDD9 NUAK1 RGPD3 FER C3 DLG4 FGFR2 GNAS TAF7 ALK MAPK8IP1 RGPD2 RANBP2 IPO7 RGPD8 RASA1 NOP53 MAGI3 SPAG9 TESK1 SMG8 NSMF KIRREL1 ROBO1 MAP3K13 TNFRSF1A TNXB EP300 | 4.36e-06 | 1421 | 262 | 39 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | RGPD4 SPRY1 CEACAM5 MYOG LILRB2 RGPD1 CEACAM6 TSC2 PPP1R15A ZEB2 MAP3K4 NEDD9 NUAK1 RGPD3 FER C3 DLG4 FGFR2 GNAS TAF7 ALK MAPK8IP1 RGPD2 RANBP2 IPO7 RGPD8 RASA1 NOP53 MAGI3 SPAG9 TESK1 SMG8 NSMF KIRREL1 ROBO1 MAP3K13 TNFRSF1A TNXB EP300 | 4.51e-06 | 1423 | 262 | 39 | GO:0051174 |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | RGPD4 SPRY1 CEACAM5 RGPD1 CEACAM6 TSC2 PPP1R15A ZEB2 MAP3K4 NEDD9 RGPD3 FER C3 DLG4 FGFR2 GNAS TAF7 ALK MAPK8IP1 RGPD2 RANBP2 IPO7 RGPD8 RASA1 NOP53 MAGI3 SPAG9 TESK1 SMG8 KIRREL1 ROBO1 MAP3K13 TNFRSF1A TNXB EP300 | 6.16e-06 | 1226 | 262 | 35 | GO:0042325 |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 7.79e-06 | 38 | 262 | 6 | GO:0000413 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | LGMN SPRY1 CEACAM5 CRIM1 EFS CEACAM8 FSTL4 CEACAM6 TSC2 NRP2 NEDD4 NEDD9 FER FGFR2 ALK RASA1 TNS2 DOK2 BCAR1 MYOF PAK3 ROBO1 REPS2 FUT7 TNXB | 1.08e-05 | 747 | 262 | 25 | GO:0007169 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | MAP1A FSTL4 TSC2 PTCH1 ZEB2 NRP2 NEDD4 NLGN3 PTPRS ANAPC2 DLG4 FGFR2 NOTCH3 B4GAT1 LAMB2 SPAG9 SRGAP2 PQBP1 PIP5K1C NSMF CELSR2 PAK3 ROBO1 MAP3K13 CDH4 EP300 | 1.25e-05 | 802 | 262 | 26 | GO:0048812 |
| GeneOntologyBiologicalProcess | pattern specification process | SPRY1 ZBTB16 TIFAB MDGA2 PTCH1 ZEB2 MAP3K4 NRP2 HOXC11 HOXC13 HOXD10 MID1 C3 FGFR2 CELSR1 CELSR2 DLL3 DCHS1 ROBO1 EP300 | 1.42e-05 | 526 | 262 | 20 | GO:0007389 |
| GeneOntologyBiologicalProcess | regulation of transferase activity | RGPD4 SPRY1 CEACAM5 RGPD1 CEACAM6 TSC2 ZEB2 MAP3K4 NEDD9 RGPD3 DLG4 FGFR2 ARRDC3 TAF7 ALK MAPK8IP1 RGPD2 RANBP2 IPO7 RGPD8 MAGI3 TESK1 SMG8 ROBO1 MAP3K13 TNXB | 1.49e-05 | 810 | 262 | 26 | GO:0051338 |
| GeneOntologyBiologicalProcess | protein localization to nucleus | RGPD4 TRAF3IP2 ZBTB16 RGPD1 TSC2 RGPD3 NPAP1 RGPD5 RGPD2 RANBP2 IPO7 RGPD8 NOP53 TESK1 TNFRSF1A EP300 | 1.73e-05 | 362 | 262 | 16 | GO:0034504 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | MAP1A FSTL4 TSC2 PTCH1 ZEB2 NRP2 NEDD4 NLGN3 PTPRS ANAPC2 DLG4 FGFR2 NOTCH3 B4GAT1 LAMB2 SPAG9 SRGAP2 PQBP1 PIP5K1C NSMF CELSR2 PAK3 ROBO1 MAP3K13 CDH4 EP300 | 1.80e-05 | 819 | 262 | 26 | GO:0120039 |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | RGPD4 CEACAM5 RGPD1 CEACAM6 ZEB2 MAP3K4 NEDD9 RGPD3 DLG4 FGFR2 ALK RGPD2 RANBP2 RGPD8 MAGI3 ROBO1 MAP3K13 | 1.83e-05 | 405 | 262 | 17 | GO:0033674 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | RGPD4 LGMN CEACAM5 CYP27B1 RGPD1 CEACAM6 DAPK1 TSC2 PPP1R15A ZEB2 MAP3K4 NEDD9 ARHGAP22 RGPD3 DLG4 FGFR2 ARRDC3 GNAS ALK ARAP1 RGPD2 RANBP2 RGPD8 MAGI3 SRGAP2 RALGAPA2 ARAP3 SNX18 ROBO1 MAP3K13 | 1.99e-05 | 1028 | 262 | 30 | GO:0043085 |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | SPRY1 CEACAM5 ZBTB16 CRIM1 LILRB2 HDAC8 FSTL4 CEACAM6 TSC2 ADGRV1 BCL6 PTCH1 KCTD11 CASZ1 PTPRS JAG1 DISP3 TJP2 NOTCH3 LILRB3 IPO7 VASN SPAG9 NOX1 ADAMTS7 CDK13 DLL3 | 2.03e-05 | 875 | 262 | 27 | GO:0045596 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | MAP1A FSTL4 TSC2 PTCH1 ZEB2 NRP2 NEDD4 NLGN3 PTPRS ANAPC2 DLG4 FGFR2 NOTCH3 B4GAT1 LAMB2 SPAG9 SRGAP2 PQBP1 PIP5K1C NSMF CELSR2 PAK3 ROBO1 MAP3K13 CDH4 EP300 | 2.08e-05 | 826 | 262 | 26 | GO:0048858 |
| GeneOntologyBiologicalProcess | dendrite development | MAP1A FSTL4 TSC2 NEDD4 NLGN3 PTPRS ANAPC2 DLG4 ALK SRGAP2 PQBP1 NSMF CELSR2 PAK3 ROBO1 | 2.73e-05 | 335 | 262 | 15 | GO:0016358 |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | SPRY1 FSTL4 ZEB2 NRP2 NLGN3 PTPRS ANAPC2 FGFR2 LAMB2 SPAG9 ROBO1 MAP3K13 CDH4 EP300 | 3.11e-05 | 299 | 262 | 14 | GO:0060560 |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 3.28e-05 | 71 | 262 | 7 | GO:0006111 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | LGMN SPRY1 CEACAM5 ZBTB16 CRIM1 LILRB2 CYP27B1 HDAC8 FSTL4 CEACAM6 TSC2 ADGRV1 BCL6 PTCH1 KCTD11 CASZ1 NLGN3 PTPRS JAG1 DISP3 TJP2 GNAS NOTCH3 LILRB3 IPO7 VASN E2F2 SPAG9 NOX1 ADAMTS7 CDK13 DLL3 ROBO1 | 3.44e-05 | 1220 | 262 | 33 | GO:0051093 |
| GeneOntologyBiologicalProcess | neuron projection development | MAP1A FSTL4 CDH23 TSC2 ADGRV1 PTCH1 ZEB2 NRP2 NEDD4 NLGN3 PTPRS ANAPC2 DLG4 LRRC7 FGFR2 ALK NOTCH3 B4GAT1 NEUROD4 LAMB2 SPAG9 SRGAP2 PQBP1 PIP5K1C FRY NOX1 NSMF CELSR2 PAK3 ROBO1 MAP3K13 CDH4 TNXB EP300 | 4.03e-05 | 1285 | 262 | 34 | GO:0031175 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 5.52e-05 | 53 | 262 | 6 | GO:0016339 | |
| GeneOntologyBiologicalProcess | axon extension | 5.83e-05 | 135 | 262 | 9 | GO:0048675 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | RGPD4 CEACAM5 LILRB2 RGPD1 CEACAM6 PPP1R15A ZEB2 MAP3K4 NEDD9 RGPD3 C3 DLG4 FGFR2 GNAS ALK RGPD2 RANBP2 RGPD8 RASA1 MAGI3 TESK1 NSMF ROBO1 MAP3K13 TNFRSF1A EP300 | 5.89e-05 | 879 | 262 | 26 | GO:0010562 |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | RGPD4 CEACAM5 LILRB2 RGPD1 CEACAM6 PPP1R15A ZEB2 MAP3K4 NEDD9 RGPD3 C3 DLG4 FGFR2 GNAS ALK RGPD2 RANBP2 RGPD8 RASA1 MAGI3 TESK1 NSMF ROBO1 MAP3K13 TNFRSF1A EP300 | 5.89e-05 | 879 | 262 | 26 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | RGPD4 CEACAM5 RGPD1 CEACAM6 ZEB2 MAP3K4 NEDD9 RGPD3 DLG4 FGFR2 ARRDC3 ALK RGPD2 RANBP2 RGPD8 MAGI3 ROBO1 MAP3K13 | 5.99e-05 | 490 | 262 | 18 | GO:0051347 |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 6.15e-05 | 54 | 262 | 6 | GO:0018208 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | RGPD4 CEACAM5 RGPD1 CEACAM6 PPP1R15A ZEB2 MAP3K4 NEDD9 RGPD3 C3 DLG4 FGFR2 GNAS ALK RGPD2 RANBP2 RGPD8 RASA1 MAGI3 TESK1 ROBO1 MAP3K13 TNFRSF1A EP300 | 6.24e-05 | 780 | 262 | 24 | GO:0042327 |
| GeneOntologyBiologicalProcess | regulation of cell development | CEACAM5 ZBTB16 MYOG LILRB2 FSTL4 HAPLN4 CEACAM6 TSC2 BCL6 ARID1A KCTD11 ZEB2 CASZ1 NEDD9 PTPRS JAG1 ANAPC2 TJP2 DLG4 GNAS LILRB3 NOX1 DLL3 PAK3 ROBO1 GRIP2 MAP3K13 TNFRSF1A CDH4 EP300 | 6.37e-05 | 1095 | 262 | 30 | GO:0060284 |
| GeneOntologyBiologicalProcess | neuron projection extension | FSTL4 NRP2 NLGN3 PTPRS ANAPC2 LAMB2 SPAG9 ROBO1 MAP3K13 CDH4 EP300 | 7.20e-05 | 207 | 262 | 11 | GO:1990138 |
| GeneOntologyBiologicalProcess | behavior | LGMN CEACAM5 TIFAB MAP1A TRPM7 LILRB2 CEACAM8 PYY CDH23 CEACAM6 MDGA2 TSC2 NEDD9 PJA2 NLGN3 HOXD10 DLG4 ARRDC3 ALK ADGRL3 AGTPBP1 NPY2R FIGN CELSR1 SHANK2 EP300 | 7.35e-05 | 891 | 262 | 26 | GO:0007610 |
| GeneOntologyBiologicalProcess | intracellular protein transport | RGPD4 TRAF3IP2 RAMP1 MAP1A RGPD1 TSC2 NEDD4 WASH6P AP2B1 RGPD3 NPAP1 OS9 LRRC7 RGPD5 RGPD2 RANBP2 IPO7 RGPD8 WASH3P WDR11 GRIP2 TNFRSF1A EP300 | 7.67e-05 | 740 | 262 | 23 | GO:0006886 |
| GeneOntologyBiologicalProcess | vesicle cargo loading | 8.70e-05 | 36 | 262 | 5 | GO:0035459 | |
| GeneOntologyBiologicalProcess | kidney development | TRAF3IP2 SPRY1 ZBTB16 PTCH1 FREM2 HOXC11 AP2B1 JAG1 FGFR2 NOTCH3 AMPD2 LAMB2 TNS2 DCHS1 ROBO1 | 8.94e-05 | 372 | 262 | 15 | GO:0001822 |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD4 TRAF3IP2 RGPD1 TSC2 ALKBH5 NEDD4 RGPD3 NPAP1 RGPD5 RGPD2 RANBP2 IPO7 RGPD8 TNFRSF1A EP300 | 1.07e-04 | 378 | 262 | 15 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD4 TRAF3IP2 RGPD1 TSC2 ALKBH5 NEDD4 RGPD3 NPAP1 RGPD5 RGPD2 RANBP2 IPO7 RGPD8 TNFRSF1A EP300 | 1.07e-04 | 378 | 262 | 15 | GO:0006913 |
| GeneOntologyBiologicalProcess | axonogenesis | MAP1A FSTL4 TSC2 PTCH1 ZEB2 NRP2 NLGN3 PTPRS ANAPC2 FGFR2 NOTCH3 B4GAT1 LAMB2 PIP5K1C PAK3 ROBO1 MAP3K13 CDH4 EP300 | 1.23e-04 | 566 | 262 | 19 | GO:0007409 |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | LILRB2 TSC2 NRP2 NEDD9 ARHGAP22 NLGN3 PTPRS SRGAP3 SHANK2 PAK3 | 1.33e-04 | 185 | 262 | 10 | GO:0099175 |
| GeneOntologyBiologicalProcess | renal system development | TRAF3IP2 SPRY1 ZBTB16 PTCH1 FREM2 HOXC11 AP2B1 JAG1 FGFR2 NOTCH3 AMPD2 LAMB2 TNS2 DCHS1 ROBO1 | 1.34e-04 | 386 | 262 | 15 | GO:0072001 |
| GeneOntologyBiologicalProcess | regionalization | SPRY1 ZBTB16 TIFAB PTCH1 ZEB2 MAP3K4 NRP2 HOXC11 HOXC13 HOXD10 C3 FGFR2 CELSR1 CELSR2 DLL3 ROBO1 EP300 | 1.42e-04 | 478 | 262 | 17 | GO:0003002 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | RGPD4 LGMN CEACAM5 CYP27B1 RGPD1 CEACAM6 DAPK1 TSC2 PPP1R15A ZEB2 MAP3K4 NEDD9 ARHGAP22 NLGN3 CLIC2 RGPD3 TMEM132A FER DLG4 FGFR2 ARRDC3 GNAS ALK ARAP1 RGPD2 RANBP2 RGPD8 MAGI3 SRGAP2 RALGAPA2 ARAP3 SNX18 ROBO1 MAP3K13 EP300 | 1.45e-04 | 1430 | 262 | 35 | GO:0044093 |
| GeneOntologyBiologicalProcess | regulation of protein modification process | SPRY1 CEACAM5 RAMP1 LILRB2 HDAC8 CEACAM6 TSC2 PPP1R15A ZEB2 MAP3K4 NEDD9 WASH6P NUAK1 FER C3 DLG4 ARRDC3 GNAS TAF7 MAPK8IP1 IPO7 RASA1 NOP53 MAGI3 SPAG9 TESK1 SMG8 WASH3P FRY NSMF KIRREL1 ROBO1 MAP3K13 TNFRSF1A TNXB EP300 | 1.46e-04 | 1488 | 262 | 36 | GO:0031399 |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 1.47e-04 | 63 | 262 | 6 | GO:0007157 | |
| GeneOntologyBiologicalProcess | intracellular transport | RGPD4 TRAF3IP2 RAMP1 MAP1A RGPD1 TSC2 ALKBH5 NEDD4 WASH6P AP2B1 RGPD3 NPAP1 OS9 LRRC7 GNAS CTAGE4 AGTPBP1 RGPD5 CTAGE9 RGPD2 RANBP2 IPO7 RGPD8 SPAG9 CTAGE6 EPG5 WASH3P YIF1B WDR11 CTAGE8 SNX18 CTAGE15 GRIP2 TNFRSF1A REPS2 EP300 | 1.62e-04 | 1496 | 262 | 36 | GO:0046907 |
| GeneOntologyBiologicalProcess | synapse assembly | HAPLN4 MDGA2 CSMD2 NLGN3 PTPRS SRGAP3 DLG4 ADGRL3 PCDHB8 SRGAP2 SHANK2 ELFN1 ROBO1 | 1.68e-04 | 308 | 262 | 13 | GO:0007416 |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 1.80e-04 | 192 | 262 | 10 | GO:0050770 | |
| GeneOntologyBiologicalProcess | regulation of MAP kinase activity | SPRY1 CEACAM5 CEACAM6 ZEB2 MAP3K4 MAPK8IP1 MAGI3 ROBO1 MAP3K13 TNXB | 1.96e-04 | 194 | 262 | 10 | GO:0043405 |
| GeneOntologyBiologicalProcess | regulation of JUN kinase activity | 2.07e-04 | 67 | 262 | 6 | GO:0043506 | |
| GeneOntologyBiologicalProcess | axon development | MAP1A FSTL4 TSC2 PTCH1 ZEB2 NRP2 NLGN3 PTPRS ANAPC2 FGFR2 NOTCH3 B4GAT1 NEUROD4 LAMB2 PIP5K1C PAK3 ROBO1 MAP3K13 CDH4 EP300 | 2.20e-04 | 642 | 262 | 20 | GO:0061564 |
| GeneOntologyBiologicalProcess | vocalization behavior | 2.21e-04 | 24 | 262 | 4 | GO:0071625 | |
| GeneOntologyBiologicalProcess | endosome to plasma membrane protein transport | 2.21e-04 | 24 | 262 | 4 | GO:0099638 | |
| GeneOntologyBiologicalProcess | podocyte development | 2.28e-04 | 10 | 262 | 3 | GO:0072015 | |
| GeneOntologyBiologicalProcess | glomerular epithelial cell development | 2.28e-04 | 10 | 262 | 3 | GO:0072310 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | FRMPD4 TRPM7 DAPK3 BCL6 ZEB2 NEDD9 WASH6P FER ARAP1 RASA1 MYOM3 ARHGEF18 BCAR1 PIP5K1C TESK1 WASH3P CELSR1 HMCN1 PAK3 KIRREL1 MYOM2 TNXB EP300 | 2.53e-04 | 803 | 262 | 23 | GO:0030036 |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 2.57e-04 | 45 | 262 | 5 | GO:0048521 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | LGMN SPRY1 CEACAM5 CRIM1 EFS FSTL5 CEACAM8 FSTL4 CEACAM6 TSC2 ZEB2 NRP2 NEDD4 NEDD9 FER FGFR2 ALK RASA1 VASN AKAP3 TNS2 DOK2 BCAR1 MYOF PAK3 ROBO1 REPS2 FUT7 TNXB EP300 | 2.58e-04 | 1186 | 262 | 30 | GO:0007167 |
| GeneOntologyBiologicalProcess | actin filament-based process | FRMPD4 TRPM7 DAPK3 BCL6 ZEB2 NEDD9 WASH6P FER CACNA1G ARAP1 RASA1 MYOM3 ARHGEF18 SRGAP2 BCAR1 PIP5K1C TESK1 WASH3P CELSR1 HMCN1 PAK3 KIRREL1 MYOM2 TNXB EP300 | 2.65e-04 | 912 | 262 | 25 | GO:0030029 |
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 2.85e-04 | 71 | 262 | 6 | GO:0099084 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | CEACAM5 ZBTB16 MYOG LILRB2 CYP27B1 HAPLN4 CEACAM6 BCL6 PTCH1 ARID1A KCTD11 ZEB2 NEDD9 JAG1 ANAPC2 DLG4 GNAS IPO7 NEUROD4 LAMB2 SPAG9 DLL3 PAK3 ROBO1 GRIP2 MAP3K13 CDH4 TNXB EP300 | 3.03e-04 | 1141 | 262 | 29 | GO:0045597 |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 3.20e-04 | 134 | 262 | 8 | GO:0010906 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | RGPD4 TRAF3IP2 RGPD1 TSC2 NEDD4 RGPD3 NPAP1 LRRC7 HSPA1L RGPD5 RGPD2 RANBP2 IPO7 RGPD8 WASH3P TNFRSF1A EP300 | 3.38e-04 | 515 | 262 | 17 | GO:0072594 |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 3.46e-04 | 103 | 262 | 7 | GO:0048814 | |
| GeneOntologyBiologicalProcess | cell junction assembly | HAPLN4 DAPK3 MDGA2 CSMD2 NLGN3 PTPRS SRGAP3 FER DLG4 ADGRL3 PCDHB8 SRGAP2 PIP5K1C CDH24 SHANK2 ELFN1 ROBO1 CDH4 | 3.78e-04 | 569 | 262 | 18 | GO:0034329 |
| GeneOntologyBiologicalProcess | cell growth | CEACAM5 CYP27B1 CEACAM8 FSTL4 CEACAM6 BCL6 ZEB2 NRP2 NLGN3 PTPRS ANAPC2 EXOSC9 LAMB2 SPAG9 BCAR1 ROBO1 MAP3K13 CDH4 EP300 | 4.27e-04 | 625 | 262 | 19 | GO:0016049 |
| GeneOntologyBiologicalProcess | regulation of neuron differentiation | BCL6 KCTD11 CASZ1 JAG1 DISP3 ALK NOTCH3 SPAG9 NOX1 GRIP2 MAP3K13 | 4.41e-04 | 255 | 262 | 11 | GO:0045664 |
| GeneOntologyBiologicalProcess | positive regulation of muscle atrophy | 4.78e-04 | 3 | 262 | 2 | GO:0014737 | |
| GeneOntologyBiologicalProcess | developmental cell growth | FSTL4 ZEB2 NRP2 NLGN3 PTPRS ANAPC2 LAMB2 SPAG9 ROBO1 MAP3K13 CDH4 EP300 | 4.98e-04 | 301 | 262 | 12 | GO:0048588 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | FSTL4 TSC2 CDKL1 ZEB2 NEDD4 NEDD9 NLGN3 PTPRS ANAPC2 FER DLG4 LRRC7 ALK ARAP1 PQBP1 TESK1 NOX1 NSMF PAK3 ROBO1 MAP3K13 CDH4 EP300 | 5.24e-04 | 846 | 262 | 23 | GO:0120035 |
| GeneOntologyBiologicalProcess | gluconeogenesis | 5.44e-04 | 111 | 262 | 7 | GO:0006094 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | MAP1A NEDD9 WASH6P NLGN3 AP2B1 TMEM132A MIEF1 DLG4 NNAT GNAS HSPA1L IPO7 TESK1 WASH3P NKD2 GRIP2 TNFRSF1A EP300 | 5.90e-04 | 591 | 262 | 18 | GO:1903829 |
| GeneOntologyBiologicalProcess | negative regulation of cell development | CEACAM5 LILRB2 FSTL4 CEACAM6 TSC2 BCL6 KCTD11 CASZ1 PTPRS TJP2 LILRB3 NOX1 DLL3 | 6.19e-04 | 353 | 262 | 13 | GO:0010721 |
| GeneOntologyBiologicalProcess | neuromuscular process | 6.34e-04 | 225 | 262 | 10 | GO:0050905 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 6.65e-04 | 14 | 262 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 6.73e-04 | 115 | 262 | 7 | GO:0019319 | |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 6.79e-04 | 150 | 262 | 8 | GO:0050773 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | FSTL4 TSC2 CDKL1 ZEB2 NEDD4 NEDD9 NLGN3 PTPRS ANAPC2 FER DLG4 LRRC7 ALK ARAP1 PQBP1 TESK1 NOX1 NSMF PAK3 ROBO1 MAP3K13 CDH4 EP300 | 6.88e-04 | 863 | 262 | 23 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 7.08e-04 | 116 | 262 | 7 | GO:0045670 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | RGPD4 TRAF3IP2 ZBTB16 MAP1A RGPD1 TSC2 PPP1R15A NEDD4 RGPD3 MID1 NPAP1 OS9 DLG4 LRRC7 HSPA1L RGPD5 RGPD2 RANBP2 IPO7 RGPD8 NOP53 TESK1 FAM83H WASH3P CEP72 TNFRSF1A EP300 | 7.37e-04 | 1091 | 262 | 27 | GO:0033365 |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 7.79e-04 | 33 | 262 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | TRPM7 CEACAM6 DAPK3 BCL6 NEDD9 JAG1 FER NPY2R RASA1 LAMB2 SRGAP2 BCAR1 TESK1 TNXB | 8.09e-04 | 410 | 262 | 14 | GO:0031589 |
| GeneOntologyBiologicalProcess | motor neuron migration | 8.23e-04 | 15 | 262 | 3 | GO:0097475 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 8.23e-04 | 15 | 262 | 3 | GO:0070347 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 9.81e-11 | 8 | 261 | 6 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 7.20e-10 | 10 | 261 | 6 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 9.88e-09 | 14 | 261 | 6 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 5.86e-08 | 18 | 261 | 6 | GO:0044615 | |
| GeneOntologyCellularComponent | adherens junction | CEACAM5 CEACAM8 CEACAM6 JAG1 FER TJP2 DLG4 LRRC7 PLEKHA7 SYNM PIP5K1C CDH24 HMCN1 ARVCF CDH4 | 7.57e-08 | 212 | 261 | 15 | GO:0005912 |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.20e-07 | 20 | 261 | 6 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.66e-07 | 21 | 261 | 6 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear pore | 4.93e-06 | 101 | 261 | 9 | GO:0005643 | |
| GeneOntologyCellularComponent | cell-cell junction | CEACAM5 CEACAM8 CEACAM6 KIAA1210 JAG1 FER TJP2 DLG4 LRRC7 PLEKHA7 ADGRL3 SYNM SGCA MAGI3 PIP5K1C CDH24 HMCN1 ARVCF KIRREL1 CDH4 | 5.76e-05 | 591 | 261 | 20 | GO:0005911 |
| GeneOntologyCellularComponent | glutamatergic synapse | FRMPD4 DAPK1 MDGA2 TSC2 CSMD2 FAAH NRP2 NEDD4 ARHGAP22 NLGN3 AP2B1 PTPRS SRGAP3 DLG4 LRRC7 ADGRL3 PRUNE2 SRGAP2 PIP5K1C NSMF SHANK2 ELFN1 PAK3 GRIP2 | 9.78e-05 | 817 | 261 | 24 | GO:0098978 |
| GeneOntologyCellularComponent | asymmetric synapse | FRMPD4 MAP1A DAPK1 TSC2 CSMD2 PJA2 NLGN3 PTPRS DLG4 LRRC7 SRGAP2 PIP5K1C NSMF SHANK2 ELFN1 PAK3 GRIP2 | 1.12e-04 | 477 | 261 | 17 | GO:0032279 |
| GeneOntologyCellularComponent | inclusion body | 1.35e-04 | 90 | 261 | 7 | GO:0016234 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 1.70e-04 | 42 | 261 | 5 | GO:0070971 | |
| GeneOntologyCellularComponent | non-motile cilium | CERKL MAP1A CDHR1 CDH23 ADGRV1 CNGA4 NPY2R PCDHB8 SHANK2 TTLL4 | 1.86e-04 | 196 | 261 | 10 | GO:0097730 |
| GeneOntologyCellularComponent | postsynaptic density | FRMPD4 MAP1A DAPK1 TSC2 CSMD2 PJA2 PTPRS DLG4 LRRC7 SRGAP2 PIP5K1C NSMF SHANK2 ELFN1 PAK3 GRIP2 | 1.88e-04 | 451 | 261 | 16 | GO:0014069 |
| GeneOntologyCellularComponent | postsynaptic specialization | FRMPD4 MAP1A DAPK1 TSC2 CSMD2 PJA2 NLGN3 PTPRS DLG4 LRRC7 SRGAP2 PIP5K1C NSMF SHANK2 ELFN1 PAK3 GRIP2 | 2.11e-04 | 503 | 261 | 17 | GO:0099572 |
| GeneOntologyCellularComponent | anchoring junction | CEACAM5 EFS CEACAM8 CEACAM6 NEDD9 ARHGAP22 KIAA1210 JAG1 FER TJP2 DLG4 LRRC7 PLEKHA7 ADGRL3 SYNM SGCA MAGI3 TNS2 BCAR1 PIP5K1C CDH24 NOX1 HMCN1 ARVCF KIRREL1 CDH4 | 2.38e-04 | 976 | 261 | 26 | GO:0070161 |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 3.32e-04 | 137 | 261 | 8 | GO:0019897 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | FRMPD4 MAP1A DAPK1 TSC2 CSMD2 PJA2 NLGN3 PTPRS DLG4 LRRC7 SRGAP2 PIP5K1C NSMF SHANK2 ELFN1 PAK3 GRIP2 | 3.32e-04 | 523 | 261 | 17 | GO:0098984 |
| GeneOntologyCellularComponent | catenin complex | 6.49e-04 | 32 | 261 | 4 | GO:0016342 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 9.55e-04 | 16 | 261 | 3 | GO:0070021 | |
| GeneOntologyCellularComponent | ciliary membrane | 1.44e-03 | 98 | 261 | 6 | GO:0060170 | |
| GeneOntologyCellularComponent | nuclear membrane | RGPD4 PHF20 RGPD1 RGPD3 NPAP1 DISP3 RGPD2 RANBP2 RGPD8 RASA1 MYOF NSMF | 1.54e-03 | 349 | 261 | 12 | GO:0031965 |
| GeneOntologyCellularComponent | transferase complex | RGPD4 CEACAM5 PIGP PHF20 RGPD1 CEACAM8 CEACAM6 DAPK1 NEDD4 RGPD3 ANAPC2 OS9 BOD1L1 TAF7 RGPD2 RANBP2 RGPD8 POLG NFS1 DCAF10 CDK13 DCAF11 EP300 | 2.30e-03 | 963 | 261 | 23 | GO:1990234 |
| MousePheno | abnormal dendrite morphology | MYT1L IP6K3 MAP1A MDGA2 TSC2 NRP2 NEDD4 NEDD9 SRGAP3 C3 DLG4 LRRC7 AGTPBP1 SRGAP2 NSMF SHANK2 ELFN1 PAK3 | 2.83e-08 | 237 | 216 | 18 | MP:0008143 |
| MousePheno | elevated level of mitotic sister chromatid exchange | 8.94e-08 | 16 | 216 | 6 | MP:0003701 | |
| MousePheno | abnormal dendritic spine morphology | MYT1L IP6K3 TSC2 NRP2 NEDD9 SRGAP3 C3 DLG4 SRGAP2 NSMF SHANK2 ELFN1 | 2.08e-07 | 115 | 216 | 12 | MP:0009936 |
| MousePheno | abnormal morula morphology | 2.26e-06 | 26 | 216 | 6 | MP:0012058 | |
| MousePheno | abnormal eye electrophysiology | RGPD4 CERKL CDHR1 RGPD1 CDH23 ADGRV1 RGPD3 C3 AGTPBP1 RGPD2 RANBP2 RGPD8 LAMB2 PRPF3 SLC24A1 | 2.58e-06 | 228 | 216 | 15 | MP:0005551 |
| MousePheno | decreased tumor latency | 5.53e-06 | 30 | 216 | 6 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 6.77e-06 | 31 | 216 | 6 | MP:0012129 | |
| MousePheno | abnormal energy homeostasis | RGPD4 CEACAM5 RGPD1 CEACAM8 CEACAM6 RGPD3 C3 CACNA1G ARRDC3 WDR13 RGPD2 RANBP2 NPY2R RGPD8 PON3 DCAF11 HDC | 1.08e-05 | 322 | 216 | 17 | MP:0005448 |
| MousePheno | abnormal tumor latency | 1.19e-05 | 34 | 216 | 6 | MP:0010307 | |
| MousePheno | abnormal rod electrophysiology | RGPD4 CERKL RGPD1 RGPD3 AGTPBP1 RGPD2 RANBP2 RGPD8 PRPF3 SLC24A1 | 1.55e-05 | 119 | 216 | 10 | MP:0004021 |
| MousePheno | increased incidence of induced tumors | RGPD4 CEACAM5 RGPD1 CEACAM6 PTCH1 RGPD3 RGPD2 RANBP2 RGPD8 POLG RALGAPA2 MAP3K6 | 1.56e-05 | 173 | 216 | 12 | MP:0002021 |
| MousePheno | abnormal neurite morphology | MYT1L IP6K3 MAP1A MDGA2 TSC2 NRP2 NEDD4 NEDD9 SRGAP3 C3 DLG4 LRRC7 ADGRL3 AGTPBP1 SRGAP2 NSMF SHANK2 ELFN1 PAK3 ROBO1 | 1.74e-05 | 442 | 216 | 20 | MP:0008415 |
| MousePheno | abnormal eye physiology | RGPD4 TRAF3IP2 CERKL ZNF274 CDHR1 RGPD1 CDH23 ADGRV1 AARS2 RGPD3 C3 AGTPBP1 RGPD2 RANBP2 RGPD8 SH3BP2 MAP3K14 LAMB2 FIGN EPG5 ARAP3 PRPF3 KIRREL1 SLC24A1 | 2.25e-05 | 606 | 216 | 24 | MP:0005253 |
| MousePheno | increased lung carcinoma incidence | 2.64e-05 | 78 | 216 | 8 | MP:0008714 | |
| MousePheno | abnormal blastocyst formation | 2.71e-05 | 39 | 216 | 6 | MP:0012128 | |
| MousePheno | abnormal energy expenditure | RGPD4 CEACAM5 RGPD1 CEACAM8 CEACAM6 RGPD3 C3 CACNA1G WDR13 RGPD2 RANBP2 NPY2R RGPD8 PON3 DCAF11 HDC | 2.92e-05 | 313 | 216 | 16 | MP:0005450 |
| MousePheno | abnormal skeletal muscle morphology | CEACAM5 MYOG CEACAM8 CEACAM6 MDGA2 NEDD4 FREM2 SULT1A3 FGFR2 HSPB8 NOTCH3 AGTPBP1 B4GAT1 SYNM SGCA POLG EPG5 MYOF SULT1A4 DLL3 EP300 | 4.06e-05 | 508 | 216 | 21 | MP:0000759 |
| MousePheno | aneuploidy | 4.10e-05 | 61 | 216 | 7 | MP:0004024 | |
| MousePheno | increased lung tumor incidence | 4.11e-05 | 107 | 216 | 9 | MP:0008014 | |
| MousePheno | increased respiratory system tumor incidence | 4.11e-05 | 107 | 216 | 9 | MP:0010298 | |
| MousePheno | abnormal chromosome number | 5.39e-05 | 86 | 216 | 8 | MP:0004023 | |
| MousePheno | increased incidence of tumors by chemical induction | RGPD4 CEACAM5 RGPD1 CEACAM6 RGPD3 RGPD2 RANBP2 RGPD8 RALGAPA2 MAP3K6 | 6.68e-05 | 141 | 216 | 10 | MP:0004499 |
| MousePheno | abnormal synaptic plasticity | 1.20e-04 | 72 | 216 | 7 | MP:0004859 | |
| MousePheno | abnormal chromosome morphology | 1.47e-04 | 126 | 216 | 9 | MP:0003702 | |
| MousePheno | increased sarcoma incidence | 1.80e-04 | 102 | 216 | 8 | MP:0002032 | |
| MousePheno | abnormal glutamate-mediated receptor currents | 1.96e-04 | 55 | 216 | 6 | MP:0002886 | |
| MousePheno | skeletal muscle fiber degeneration | 2.70e-04 | 21 | 216 | 4 | MP:0009412 | |
| MousePheno | head shaking | 3.26e-04 | 22 | 216 | 4 | MP:0002730 | |
| MousePheno | obese | 3.64e-04 | 113 | 216 | 8 | MP:0001261 | |
| MousePheno | abnormal cerebellar molecular layer | 3.80e-04 | 62 | 216 | 6 | MP:0000889 | |
| MousePheno | increased susceptibility to age-related hearing loss | 3.90e-04 | 23 | 216 | 4 | MP:0004748 | |
| Domain | Ran_BP1 | 6.09e-11 | 12 | 255 | 7 | PF00638 | |
| Domain | RANBD1 | 6.09e-11 | 12 | 255 | 7 | PS50196 | |
| Domain | RanBD | 1.30e-10 | 13 | 255 | 7 | SM00160 | |
| Domain | Ran_bind_dom | 1.30e-10 | 13 | 255 | 7 | IPR000156 | |
| Domain | Grip | 2.67e-09 | 11 | 255 | 6 | SM00755 | |
| Domain | GRIP | 2.67e-09 | 11 | 255 | 6 | PF01465 | |
| Domain | GRIP_dom | 5.27e-09 | 12 | 255 | 6 | IPR000237 | |
| Domain | GRIP | 5.27e-09 | 12 | 255 | 6 | PS50913 | |
| Domain | Rab_bind | 9.37e-09 | 7 | 255 | 5 | PF16704 | |
| Domain | GCC2_Rab_bind | 9.37e-09 | 7 | 255 | 5 | IPR032023 | |
| Domain | PH_dom-like | RGPD4 FRMPD4 RGPD1 PRKD3 ARHGAP22 RGPD3 PLEKHA7 ARAP1 RGPD5 MAPK8IP1 RGPD2 RANBP2 RGPD8 RASA1 ARHGAP23 SH3BP2 ARHGEF18 TNS2 DOK2 PLEKHA6 PTPN21 ARAP3 PLEKHG6 | 2.31e-08 | 426 | 255 | 23 | IPR011993 |
| Domain | CA | CDHR1 CDH23 FREM2 PCDHGB2 PCDHGA9 PCDHB8 CDH24 CELSR1 CELSR2 DCHS1 CDH4 PCDHGA8 | 5.76e-08 | 115 | 255 | 12 | SM00112 |
| Domain | Cadherin-like | CDHR1 CDH23 PCDHGB2 SGCA PCDHGA9 PCDHB8 CDH24 CELSR1 CELSR2 DCHS1 CDH4 PCDHGA8 | 6.34e-08 | 116 | 255 | 12 | IPR015919 |
| Domain | Cadherin | CDHR1 CDH23 FREM2 PCDHGB2 PCDHGA9 PCDHB8 CDH24 CELSR1 CELSR2 DCHS1 CDH4 PCDHGA8 | 7.68e-08 | 118 | 255 | 12 | IPR002126 |
| Domain | - | RGPD4 RGPD1 PRKD3 ARHGAP22 RGPD3 PLEKHA7 ARAP1 MAPK8IP1 RGPD2 RANBP2 RGPD8 RASA1 ARHGAP23 SH3BP2 ARHGEF18 TNS2 DOK2 PLEKHA6 PTPN21 ARAP3 PLEKHG6 | 1.06e-07 | 391 | 255 | 21 | 2.30.29.30 |
| Domain | - | 1.09e-07 | 10 | 255 | 5 | 1.10.220.60 | |
| Domain | Cadherin_CS | CDHR1 CDH23 PCDHGB2 PCDHGA9 PCDHB8 CDH24 CELSR1 CELSR2 DCHS1 CDH4 PCDHGA8 | 2.92e-07 | 109 | 255 | 11 | IPR020894 |
| Domain | CADHERIN_1 | CDHR1 CDH23 PCDHGB2 PCDHGA9 PCDHB8 CDH24 CELSR1 CELSR2 DCHS1 CDH4 PCDHGA8 | 4.22e-07 | 113 | 255 | 11 | PS00232 |
| Domain | Cadherin | CDHR1 CDH23 PCDHGB2 PCDHGA9 PCDHB8 CDH24 CELSR1 CELSR2 DCHS1 CDH4 PCDHGA8 | 4.22e-07 | 113 | 255 | 11 | PF00028 |
| Domain | CADHERIN_2 | CDHR1 CDH23 PCDHGB2 PCDHGA9 PCDHB8 CDH24 CELSR1 CELSR2 DCHS1 CDH4 PCDHGA8 | 4.62e-07 | 114 | 255 | 11 | PS50268 |
| Domain | - | CDHR1 CDH23 PCDHGB2 PCDHGA9 PCDHB8 CDH24 CELSR1 CELSR2 DCHS1 CDH4 PCDHGA8 | 4.62e-07 | 114 | 255 | 11 | 2.60.40.60 |
| Domain | Ig_I-set | CEACAM5 FSTL5 CEACAM8 FSTL4 CEACAM6 MDGA2 PTPRS FGFR2 MYOM3 HMCN1 KIRREL1 ROBO1 MYOM2 | 2.20e-06 | 190 | 255 | 13 | IPR013098 |
| Domain | I-set | CEACAM5 FSTL5 CEACAM8 FSTL4 CEACAM6 MDGA2 PTPRS FGFR2 MYOM3 HMCN1 KIRREL1 ROBO1 MYOM2 | 2.20e-06 | 190 | 255 | 13 | PF07679 |
| Domain | DAPK1 | 2.52e-06 | 3 | 255 | 3 | IPR020676 | |
| Domain | IGc2 | CEACAM5 FSTL5 CEACAM8 FSTL4 HAPLN4 CEACAM6 MDGA2 PTPRS FGFR2 MYOM3 HMCN1 KIRREL1 ROBO1 MYOM2 | 4.55e-06 | 235 | 255 | 14 | SM00408 |
| Domain | Ig_sub2 | CEACAM5 FSTL5 CEACAM8 FSTL4 HAPLN4 CEACAM6 MDGA2 PTPRS FGFR2 MYOM3 HMCN1 KIRREL1 ROBO1 MYOM2 | 4.55e-06 | 235 | 255 | 14 | IPR003598 |
| Domain | CAS_DUF3513 | 9.96e-06 | 4 | 255 | 3 | IPR021901 | |
| Domain | DUF3513 | 9.96e-06 | 4 | 255 | 3 | PF12026 | |
| Domain | Ig-like_fold | IL13RA2 CEACAM5 HLA-DQB1 LILRB2 FSTL5 CEACAM8 FSTL4 HAPLN4 CEACAM6 MDGA2 PTPRS MID1 FGFR2 LILRB3 SGCA VASN MYOM3 FSD2 SHANK2 HMCN1 FCRLB KIRREL1 ROBO1 MYOM2 TNXB | 1.38e-05 | 706 | 255 | 25 | IPR013783 |
| Domain | WW_DOMAIN_1 | 6.57e-05 | 51 | 255 | 6 | PS01159 | |
| Domain | WW_DOMAIN_2 | 6.57e-05 | 51 | 255 | 6 | PS50020 | |
| Domain | IG | CEACAM5 LILRB2 FSTL5 CEACAM8 FSTL4 HAPLN4 CEACAM6 MDGA2 PTPRS FGFR2 LILRB3 MYOM3 HMCN1 FCRLB KIRREL1 ROBO1 MYOM2 | 7.18e-05 | 421 | 255 | 17 | SM00409 |
| Domain | Ig_sub | CEACAM5 LILRB2 FSTL5 CEACAM8 FSTL4 HAPLN4 CEACAM6 MDGA2 PTPRS FGFR2 LILRB3 MYOM3 HMCN1 FCRLB KIRREL1 ROBO1 MYOM2 | 7.18e-05 | 421 | 255 | 17 | IPR003599 |
| Domain | WW_dom | 7.35e-05 | 52 | 255 | 6 | IPR001202 | |
| Domain | GPS | 9.18e-05 | 34 | 255 | 5 | SM00303 | |
| Domain | GPS | 1.06e-04 | 35 | 255 | 5 | PF01825 | |
| Domain | - | IL13RA2 CEACAM5 HLA-DQB1 FSTL5 CEACAM8 FSTL4 HAPLN4 CEACAM6 MDGA2 PTPRS MID1 FGFR2 SGCA VASN MYOM3 FSD2 HMCN1 FCRLB KIRREL1 ROBO1 MYOM2 TNXB | 1.19e-04 | 663 | 255 | 22 | 2.60.40.10 |
| Domain | GPS | 1.22e-04 | 36 | 255 | 5 | PS50221 | |
| Domain | GPS | 1.39e-04 | 37 | 255 | 5 | IPR000203 | |
| Domain | PDZ | 1.40e-04 | 141 | 255 | 9 | PF00595 | |
| Domain | IG_LIKE | CEACAM5 HLA-DQB1 LILRB2 FSTL5 CEACAM8 FSTL4 HAPLN4 CEACAM6 MDGA2 PTPRS FGFR2 LILRB3 MYOM3 HMCN1 FCRLB KIRREL1 ROBO1 MYOM2 | 1.50e-04 | 491 | 255 | 18 | PS50835 |
| Domain | SH3 | EFS NEDD9 SRGAP3 TJP2 DLG4 MAPK8IP1 RASA1 SRGAP2 BCAR1 SHANK2 SNX18 | 1.96e-04 | 216 | 255 | 11 | SM00326 |
| Domain | SH3 | EFS NEDD9 SRGAP3 TJP2 DLG4 MAPK8IP1 RASA1 SRGAP2 BCAR1 SHANK2 SNX18 | 1.96e-04 | 216 | 255 | 11 | PS50002 |
| Domain | RhoGAP | 1.98e-04 | 62 | 255 | 6 | SM00324 | |
| Domain | Ig-like_dom | CEACAM5 HLA-DQB1 LILRB2 FSTL5 CEACAM8 FSTL4 HAPLN4 CEACAM6 MDGA2 PTPRS FGFR2 LILRB3 MYOM3 HMCN1 FCRLB KIRREL1 ROBO1 MYOM2 | 2.01e-04 | 503 | 255 | 18 | IPR007110 |
| Domain | PDZ | 2.02e-04 | 148 | 255 | 9 | SM00228 | |
| Domain | Rho_GTPase_activation_prot | 2.02e-04 | 88 | 255 | 7 | IPR008936 | |
| Domain | PROTEIN_KINASE_ATP | DAPK2 DAPK1 DAPK3 CDKL1 MAP3K4 PRKD3 NUAK1 FER FGFR2 ALK MAP3K14 MAP3K6 TESK1 CDK13 PAK3 MAP3K13 NEK11 | 2.02e-04 | 459 | 255 | 17 | PS00107 |
| Domain | RhoGAP | 2.16e-04 | 63 | 255 | 6 | PF00620 | |
| Domain | - | 2.23e-04 | 150 | 255 | 9 | 2.30.42.10 | |
| Domain | SH3_domain | EFS NEDD9 SRGAP3 TJP2 DLG4 MAPK8IP1 RASA1 SRGAP2 BCAR1 SHANK2 SNX18 | 2.29e-04 | 220 | 255 | 11 | IPR001452 |
| Domain | PDZ | 2.34e-04 | 151 | 255 | 9 | PS50106 | |
| Domain | RhoGAP_dom | 2.36e-04 | 64 | 255 | 6 | IPR000198 | |
| Domain | RHOGAP | 2.36e-04 | 64 | 255 | 6 | PS50238 | |
| Domain | - | 2.36e-04 | 64 | 255 | 6 | 1.10.555.10 | |
| Domain | Protein_kinase_ATP_BS | DAPK2 DAPK1 DAPK3 CDKL1 MAP3K4 PRKD3 NUAK1 FER FGFR2 ALK MAP3K14 MAP3K6 TESK1 CDK13 PAK3 | 2.37e-04 | 379 | 255 | 15 | IPR017441 |
| Domain | PDZ | 2.46e-04 | 152 | 255 | 9 | IPR001478 | |
| Domain | ig | CEACAM5 FSTL5 CEACAM8 FSTL4 CEACAM6 MDGA2 PTPRS LILRB3 MYOM3 HMCN1 | 2.92e-04 | 190 | 255 | 10 | PF00047 |
| Domain | Immunoglobulin | CEACAM5 FSTL5 CEACAM8 FSTL4 CEACAM6 MDGA2 PTPRS LILRB3 MYOM3 HMCN1 | 2.92e-04 | 190 | 255 | 10 | IPR013151 |
| Domain | Growth_fac_rcpt_ | 2.99e-04 | 156 | 255 | 9 | IPR009030 | |
| Domain | EGF | 3.40e-04 | 126 | 255 | 8 | PF00008 | |
| Domain | GAIN_dom_N | 3.83e-04 | 11 | 255 | 3 | IPR032471 | |
| Domain | GAIN | 3.83e-04 | 11 | 255 | 3 | PF16489 | |
| Domain | Prot_kinase_dom | DAPK2 DAPK1 DAPK3 CDKL1 MAP3K4 PRKD3 NUAK1 FER FGFR2 ALK MAP3K14 MAP3K6 TESK1 CDK13 PAK3 MAP3K13 NEK11 | 4.21e-04 | 489 | 255 | 17 | IPR000719 |
| Domain | FN3 | 4.22e-04 | 199 | 255 | 10 | PS50853 | |
| Domain | SH3_1 | 4.31e-04 | 164 | 255 | 9 | PF00018 | |
| Domain | WW | 4.38e-04 | 47 | 255 | 5 | PF00397 | |
| Domain | PH | PRKD3 ARHGAP22 PLEKHA7 ARAP1 RASA1 ARHGAP23 SH3BP2 ARHGEF18 DOK2 PLEKHA6 ARAP3 PLEKHG6 | 4.61e-04 | 278 | 255 | 12 | SM00233 |
| Domain | PROTEIN_KINASE_DOM | DAPK2 DAPK1 DAPK3 CDKL1 MAP3K4 PRKD3 NUAK1 FER FGFR2 ALK MAP3K14 MAP3K6 TESK1 CDK13 PAK3 MAP3K13 NEK11 | 4.62e-04 | 493 | 255 | 17 | PS50011 |
| Domain | PH_DOMAIN | PRKD3 ARHGAP22 PLEKHA7 ARAP1 RASA1 ARHGAP23 SH3BP2 ARHGEF18 DOK2 PLEKHA6 ARAP3 PLEKHG6 | 4.76e-04 | 279 | 255 | 12 | PS50003 |
| Domain | WW | 4.84e-04 | 48 | 255 | 5 | SM00456 | |
| Domain | PH_domain | PRKD3 ARHGAP22 PLEKHA7 ARAP1 RASA1 ARHGAP23 SH3BP2 ARHGEF18 DOK2 PLEKHA6 ARAP3 PLEKHG6 | 4.91e-04 | 280 | 255 | 12 | IPR001849 |
| Domain | Kinase-like_dom | TRPM7 DAPK2 DAPK1 DAPK3 CDKL1 MAP3K4 PRKD3 NUAK1 FER FGFR2 ALK MAP3K14 MAP3K6 TESK1 CDK13 PAK3 MAP3K13 NEK11 | 4.92e-04 | 542 | 255 | 18 | IPR011009 |
| Domain | hEGF | 5.37e-04 | 28 | 255 | 4 | PF12661 | |
| Domain | Serine_rich | 5.52e-04 | 3 | 255 | 2 | IPR014928 | |
| Domain | Serine_rich | 5.52e-04 | 3 | 255 | 2 | PF08824 | |
| Domain | FN3_dom | 6.19e-04 | 209 | 255 | 10 | IPR003961 | |
| Domain | Pkinase | DAPK2 DAPK1 DAPK3 CDKL1 MAP3K4 PRKD3 NUAK1 MAP3K14 MAP3K6 TESK1 CDK13 PAK3 MAP3K13 NEK11 | 7.91e-04 | 381 | 255 | 14 | PF00069 |
| Domain | FHA | 7.99e-04 | 31 | 255 | 4 | PF00498 | |
| Domain | PH | PRKD3 ARHGAP22 PLEKHA7 ARAP1 RASA1 SH3BP2 ARHGEF18 DOK2 PLEKHA6 ARAP3 | 1.24e-03 | 229 | 255 | 10 | PF00169 |
| Domain | Ser/Thr_kinase_AS | DAPK2 DAPK1 DAPK3 CDKL1 MAP3K4 PRKD3 NUAK1 MAP3K14 MAP3K6 CDK13 PAK3 MAP3K13 NEK11 | 1.31e-03 | 357 | 255 | 13 | IPR008271 |
| Domain | S_TKc | DAPK2 DAPK1 DAPK3 CDKL1 MAP3K4 PRKD3 NUAK1 MAP3K14 MAP3K6 CDK13 PAK3 MAP3K13 NEK11 | 1.38e-03 | 359 | 255 | 13 | SM00220 |
| Domain | - | 1.42e-03 | 36 | 255 | 4 | 2.60.200.20 | |
| Domain | FHA_dom | 1.42e-03 | 36 | 255 | 4 | IPR000253 | |
| Domain | PROTEIN_KINASE_ST | DAPK2 DAPK1 DAPK3 CDKL1 MAP3K4 PRKD3 NUAK1 MAP3K14 MAP3K6 CDK13 PAK3 MAP3K13 NEK11 | 1.48e-03 | 362 | 255 | 13 | PS00108 |
| Domain | fn3 | 1.76e-03 | 162 | 255 | 8 | PF00041 | |
| Domain | MAM | 1.76e-03 | 18 | 255 | 3 | PF00629 | |
| Domain | MAM_dom | 1.76e-03 | 18 | 255 | 3 | IPR000998 | |
| Domain | MAM_2 | 1.76e-03 | 18 | 255 | 3 | PS50060 | |
| Domain | DSL | 1.81e-03 | 5 | 255 | 2 | PS51051 | |
| Domain | Notch_ligand_N | 1.81e-03 | 5 | 255 | 2 | IPR011651 | |
| Domain | Gal_Lectin | 1.81e-03 | 5 | 255 | 2 | PF02140 | |
| Domain | MNNL | 1.81e-03 | 5 | 255 | 2 | PF07657 | |
| Domain | DSL | 1.81e-03 | 5 | 255 | 2 | IPR001774 | |
| Domain | Lectin_gal-bd_dom | 1.81e-03 | 5 | 255 | 2 | IPR000922 | |
| Domain | SUEL_LECTIN | 1.81e-03 | 5 | 255 | 2 | PS50228 | |
| Domain | GPCR_2_extracellular_dom | 2.11e-03 | 40 | 255 | 4 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 2.11e-03 | 40 | 255 | 4 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 2.11e-03 | 40 | 255 | 4 | PS50227 | |
| Domain | Cadherin_C | 2.53e-03 | 42 | 255 | 4 | IPR032455 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.11e-07 | 18 | 197 | 6 | MM1549 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 5.41e-06 | 92 | 197 | 9 | MM14951 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | ARHGAP22 SRGAP3 JAG1 ARAP1 ARHGAP23 ESYT1 ARHGEF18 SRGAP2 ARAP3 NOX1 PLEKHG6 PAK3 | 6.37e-06 | 175 | 197 | 12 | MM15599 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | ARHGAP22 SRGAP3 JAG1 ARAP1 ARHGAP23 ESYT1 ARHGEF18 SRGAP2 ARAP3 NOX1 PLEKHG6 PAK3 | 1.06e-05 | 184 | 197 | 12 | M41809 |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.78e-05 | 40 | 197 | 6 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.07e-05 | 41 | 197 | 6 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.38e-05 | 42 | 197 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.74e-05 | 43 | 197 | 6 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 4.60e-05 | 47 | 197 | 6 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 5.85e-05 | 49 | 197 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 6.57e-05 | 50 | 197 | 6 | MM14610 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 6.99e-05 | 73 | 197 | 7 | MM14948 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 7.37e-05 | 51 | 197 | 6 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.13e-04 | 55 | 197 | 6 | MM14917 | |
| Pathway | REACTOME_INACTIVATION_OF_CDC42_AND_RAC1 | 1.43e-04 | 8 | 197 | 3 | M27349 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.53e-04 | 58 | 197 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.53e-04 | 58 | 197 | 6 | MM14736 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 1.84e-04 | 60 | 197 | 6 | M40048 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 2.87e-04 | 65 | 197 | 6 | MM15147 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RGPD4 RGPD1 ARHGAP22 SRGAP3 JAG1 RGPD3 TJP2 DLG4 ARAP1 RGPD2 RANBP2 RGPD8 ARHGAP23 ESYT1 ARHGEF18 SRGAP2 ARAP3 NOX1 PLEKHG6 WDR11 PAK3 | 2.98e-04 | 649 | 197 | 21 | MM15690 |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND | 3.00e-04 | 10 | 197 | 3 | M866 | |
| Pubmed | 1.47e-12 | 7 | 271 | 6 | 9037092 | ||
| Pubmed | 1.47e-12 | 7 | 271 | 6 | 21205196 | ||
| Pubmed | 1.47e-12 | 7 | 271 | 6 | 24403063 | ||
| Pubmed | 1.47e-12 | 7 | 271 | 6 | 23536549 | ||
| Pubmed | 1.47e-12 | 7 | 271 | 6 | 12191015 | ||
| Pubmed | 1.47e-12 | 7 | 271 | 6 | 22821000 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.47e-12 | 7 | 271 | 6 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.47e-12 | 7 | 271 | 6 | 11353387 | |
| Pubmed | 1.47e-12 | 7 | 271 | 6 | 30944974 | ||
| Pubmed | 1.47e-12 | 7 | 271 | 6 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.47e-12 | 7 | 271 | 6 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.47e-12 | 7 | 271 | 6 | 17372272 | |
| Pubmed | 1.47e-12 | 7 | 271 | 6 | 38657106 | ||
| Pubmed | 1.47e-12 | 7 | 271 | 6 | 18949001 | ||
| Pubmed | 1.47e-12 | 7 | 271 | 6 | 25187515 | ||
| Pubmed | 1.47e-12 | 7 | 271 | 6 | 8603673 | ||
| Pubmed | 1.47e-12 | 7 | 271 | 6 | 26632511 | ||
| Pubmed | 1.47e-12 | 7 | 271 | 6 | 23818861 | ||
| Pubmed | 1.47e-12 | 7 | 271 | 6 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 5.85e-12 | 8 | 271 | 6 | 21670213 | |
| Pubmed | 5.85e-12 | 8 | 271 | 6 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 5.85e-12 | 8 | 271 | 6 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 5.85e-12 | 8 | 271 | 6 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 5.85e-12 | 8 | 271 | 6 | 28745977 | |
| Pubmed | 1.74e-11 | 9 | 271 | 6 | 28100513 | ||
| Pubmed | 1.74e-11 | 9 | 271 | 6 | 17887960 | ||
| Pubmed | 1.74e-11 | 9 | 271 | 6 | 9733766 | ||
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.74e-11 | 9 | 271 | 6 | 18394993 | |
| Pubmed | 1.74e-11 | 9 | 271 | 6 | 11553612 | ||
| Pubmed | 1.74e-11 | 9 | 271 | 6 | 10601307 | ||
| Pubmed | 1.74e-11 | 9 | 271 | 6 | 28877029 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 4.33e-11 | 10 | 271 | 6 | 16332688 | |
| Pubmed | 4.33e-11 | 10 | 271 | 6 | 27160050 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 4.33e-11 | 10 | 271 | 6 | 8857542 | |
| Pubmed | 4.33e-11 | 10 | 271 | 6 | 21859863 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TSC2 ATG2A PTCH1 ARID1A CASZ1 NUAK1 PTPRS TMEM132A FGFR2 ARAP1 TEAD2 ESYT1 POLG MYOM3 LAMB2 SRGAP2 MED13L RALGAPA2 PIP5K1C TESK1 KIFC2 FAM83H MYOF CELSR1 ARAP3 SHANK2 CELSR2 ADAMTS7 ARVCF CDK13 TTLL4 EP300 AHNAK2 | 4.90e-11 | 1105 | 271 | 33 | 35748872 |
| Pubmed | 9.47e-11 | 11 | 271 | 6 | 17069463 | ||
| Pubmed | 9.47e-11 | 11 | 271 | 6 | 34110283 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 9.47e-11 | 11 | 271 | 6 | 35771867 | |
| Pubmed | RGPD4 RGPD1 DAPK1 DAPK3 TSC2 ZEB2 NEDD4 NLGN3 AP2B1 PTPRS SRGAP3 RGPD3 DLG4 LRRC7 MAPK8IP1 RGPD2 AMPD2 RANBP2 DMXL2 RGPD8 ARHGEF18 DIDO1 SRGAP2 FRY TXLNA SHANK2 CELSR2 ARVCF DCHS1 PAK3 | 1.46e-10 | 963 | 271 | 30 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ZBTB16 TRPM7 DAPK2 DAPK3 TSC2 CBARP NEDD4 PJA2 TCERG1 STARD9 TJP2 MIEF1 BOD1L1 GNAS PLEKHA7 AMPD2 ESYT1 MAP3K14 MAGI3 SRGAP2 PTPN21 BCAR1 MAP3K6 TESK1 FAM83H KIAA1671 NKD2 AHNAK2 | 2.38e-10 | 861 | 271 | 28 | 36931259 |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 3.47e-10 | 13 | 271 | 6 | 31427429 | |
| Pubmed | 9.99e-10 | 15 | 271 | 6 | 14697343 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | MAP1A ATG2A PTCH1 NEDD4 NEDD9 AP2B1 ARRDC3 TMEM252 PLEKHA7 ADGRL3 ARAP1 PRUNE2 IPO7 ARHGEF18 BCAR1 PIP5K1C KIAA1671 FAM193A | 1.00e-08 | 430 | 271 | 18 | 35044719 |
| Pubmed | 1.42e-08 | 22 | 271 | 6 | 27717094 | ||
| Pubmed | Characterization of the murine orthologue of a novel human subtelomeric multigene family. | 1.79e-08 | 5 | 271 | 4 | 11701968 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | RGPD4 MAP1A RGPD1 TSC2 NEDD4 RGPD3 TJP2 LRRC7 RGPD2 RANBP2 RGPD8 PLEKHA6 SHANK2 | 3.93e-08 | 231 | 271 | 13 | 16452087 |
| Pubmed | Human subtelomeric WASH genes encode a new subclass of the WASP family. | 5.34e-08 | 6 | 271 | 4 | 18159949 | |
| Pubmed | 5.37e-08 | 67 | 271 | 8 | 29254152 | ||
| Pubmed | CASZ1 NLGN3 AARS2 TMEM132A DISP3 PRUNE2 DMXL2 ARHGAP23 SYNM ARHGEF18 MAGI3 SPAG9 PLEKHA6 RALGAPA2 MYOF WDR11 CEP72 CDK13 | 7.95e-08 | 493 | 271 | 18 | 15368895 | |
| Pubmed | MYT1L PIGP CRIM1 TRPM7 TSC2 ARID1A ZEB2 AP2B1 TCERG1 DLG4 WDR13 AGTPBP1 MAPK8IP1 DMXL2 EXOSC9 B4GAT1 SYNM POLG MAGI3 SRGAP2 MED13L CBR1 CBR3 TDP2 FRY NSMF ROBO1 TMEM131 REPS2 EP300 | 1.03e-07 | 1285 | 271 | 30 | 35914814 | |
| Pubmed | FRMPD4 FSTL5 ZEB2 MAP3K4 NEDD4 PJA2 SRGAP3 STARD9 BOD1L1 LRRC7 ARRDC3 ADGRL3 AGTPBP1 MED13L PIP5K1C EPG5 | 1.58e-07 | 407 | 271 | 16 | 12693553 | |
| Pubmed | ARID1A TCERG1 LRRC7 PLEKHA7 RANBP2 SYNM ESYT1 KIAA1671 FAM193A NKD2 KIRREL1 TMEM131 AHNAK2 | 1.78e-07 | 263 | 271 | 13 | 34702444 | |
| Pubmed | MYT1L ADGRV1 SRGAP3 CACNA1G ARAP1 PRUNE2 DMXL2 SPAG9 MED13L MYOF CEP72 GRIP2 | 2.36e-07 | 225 | 271 | 12 | 12168954 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZBTB16 RAMP1 HDAC8 ADGRV1 ARID1A CASZ1 NLGN3 ZNF544 PTPRS OS9 BOD1L1 LRRC7 GNAS WDR13 NOTCH3 ARAP1 PRUNE2 RASA1 POLG SH3BP2 ARHGEF18 MAGI3 SRGAP2 BCAR1 KIAA1671 SHANK2 WDR11 PRPF3 CDK13 RBM6 PAK3 EP300 | 2.40e-07 | 1489 | 271 | 32 | 28611215 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | DAPK3 MAP3K4 PRKD3 NUAK1 AP2B1 ANAPC2 FER FGFR2 ARHGAP23 NOL11 TNS2 BCAR1 NFS1 MAP3K6 FAM83H MYOF TXLNA YIF1B TRMT2A CDK13 PAK3 MAP3K13 REPS2 EP300 | 2.44e-07 | 910 | 271 | 24 | 36736316 |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 3.77e-07 | 153 | 271 | 10 | 26365490 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | MAP1A NEDD4 NLGN3 AP2B1 SRGAP3 DLG4 LRRC7 GNAS DMXL2 ARHGEF18 SRGAP2 PQBP1 SHANK2 | 3.79e-07 | 281 | 271 | 13 | 28706196 |
| Pubmed | ZBTB16 MYOG BCL6 NEDD9 PRKD3 UGP2 OS9 HSPB8 NOTCH3 AGTPBP1 RANBP2 DMXL2 IPO7 SGCA MYOM3 FSD2 MYOM2 | 4.57e-07 | 497 | 271 | 17 | 23414517 | |
| Pubmed | The death-associated protein kinases: structure, function, and beyond. | 4.68e-07 | 3 | 271 | 3 | 16756490 | |
| Pubmed | 4.68e-07 | 3 | 271 | 3 | 11597768 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 4.74e-07 | 38 | 271 | 6 | 12791264 | |
| Pubmed | ZBTB16 NEDD4 NEDD9 HOXD10 FGFR2 TAF7 NOTCH3 NEUROD4 LAMB2 DLL3 TNXB | 9.00e-07 | 210 | 271 | 11 | 16537572 | |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 9.42e-07 | 67 | 271 | 7 | 21875946 | |
| Pubmed | 1.86e-06 | 4 | 271 | 3 | 26483485 | ||
| Pubmed | The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms. | 1.86e-06 | 4 | 271 | 3 | 37224017 | |
| Pubmed | 1.86e-06 | 4 | 271 | 3 | 9748319 | ||
| Pubmed | 1.86e-06 | 4 | 271 | 3 | 9480752 | ||
| Pubmed | ZNF274 EFS CSMD2 UGP2 DLG4 NOTCH3 BCAR1 NFS1 KIFC2 SHANK2 CELSR2 GRIP2 SLC24A1 | 2.20e-06 | 329 | 271 | 13 | 17474147 | |
| Pubmed | 3.29e-06 | 152 | 271 | 9 | 34299191 | ||
| Pubmed | TRAF3IP2 WASH6P FREM2 TCERG1 MID1 ANAPC2 NMT1 DMXL2 ARHGAP23 DIDO1 MAP3K6 SMG8 TXLNA ARAP3 TRMT2A WDR11 ARVCF CDK13 | 4.19e-06 | 650 | 271 | 18 | 38777146 | |
| Pubmed | MAP3Ks as central regulators of cell fate during development. | 4.60e-06 | 15 | 271 | 4 | 18855897 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MAP1A DHX8 FER TJP2 TAF7 NMT1 AGTPBP1 RANBP2 NOL11 SRGAP2 PQBP1 CBR1 TDP2 MYOF TXLNA FAM193A SNX18 TMEM131 AHNAK2 | 4.88e-06 | 724 | 271 | 19 | 36232890 |
| Pubmed | 5.13e-06 | 86 | 271 | 7 | 37253089 | ||
| Pubmed | Genome-wide association study for serum complement C3 and C4 levels in healthy Chinese subjects. | 7.92e-06 | 17 | 271 | 4 | 23028341 | |
| Pubmed | A novel receptor tyrosine phosphatase-sigma that is highly expressed in the nervous system. | 9.20e-06 | 6 | 271 | 3 | 8227050 | |
| Pubmed | 9.20e-06 | 6 | 271 | 3 | 11672528 | ||
| Pubmed | 1.04e-05 | 133 | 271 | 8 | 15144186 | ||
| Pubmed | SPRY1 DAPK1 BCL6 FREM2 AARS2 PTPRS OS9 FGFR2 NNAT GNAS PLEKHA7 AGTPBP1 CTAGE9 ARHGAP23 LAMB2 DIDO1 BCAR1 PQBP1 FAM83H NSMF FER1L4 CTAGE8 SNX18 CHCHD2 EP300 | 1.13e-05 | 1215 | 271 | 25 | 15146197 | |
| Pubmed | 1.60e-05 | 7 | 271 | 3 | 21655271 | ||
| Pubmed | WASH maintains NKp46+ ILC3 cells by promoting AHR expression. | 1.60e-05 | 7 | 271 | 3 | 28589939 | |
| Pubmed | 1.60e-05 | 7 | 271 | 3 | 12438748 | ||
| Pubmed | Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. | 1.94e-05 | 21 | 271 | 4 | 25249183 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 2.15e-05 | 72 | 271 | 6 | 10380929 | |
| Pubmed | Differentially regulated and evolved genes in the fully sequenced Xq/Yq pseudoautosomal region. | 2.55e-05 | 8 | 271 | 3 | 10655549 | |
| Pubmed | 2.55e-05 | 8 | 271 | 3 | 29662228 | ||
| Pubmed | RGPD4 RGPD1 ARID1A ZEB2 AP2B1 STARD9 RGPD3 UGP2 BOD1L1 CTAGE4 HSPA1L RGPD5 RGPD2 RANBP2 RGPD8 PCDHGB2 PCDHGA9 MAGI3 CTAGE6 PTPN21 CAPN11 SHANK2 CDK13 CTAGE8 CTAGE15 MYOM2 PCDHGA8 | 2.64e-05 | 1442 | 271 | 27 | 35575683 | |
| Pubmed | 2.65e-05 | 197 | 271 | 9 | 36604605 | ||
| Pubmed | 2.86e-05 | 153 | 271 | 8 | 10718198 | ||
| Pubmed | DAPK3 BCKDHB CBARP ARID1A PTPRS PLEKHA7 AGTPBP1 RANBP2 IPO7 NOP53 TNS2 SPAG9 PTPN21 BCAR1 PQBP1 KIAA1671 WDR11 ARVCF PRPF3 CEP72 KIRREL1 ROBO1 | 2.91e-05 | 1049 | 271 | 22 | 27880917 | |
| Pubmed | 2.92e-05 | 46 | 271 | 5 | 20301533 | ||
| Pubmed | 3.08e-05 | 251 | 271 | 10 | 29031500 | ||
| Pubmed | 3.16e-05 | 77 | 271 | 6 | 10835267 | ||
| Pubmed | RGPD4 FRMPD4 MAP1A RGPD1 CBARP PJA2 SRGAP3 RGPD3 TJP2 DLG4 LRRC7 ADGRL3 MAPK8IP1 RGPD2 AMPD2 RANBP2 DMXL2 RGPD8 NFS1 SHANK2 CELSR2 ELFN1 PAK3 | 3.43e-05 | 1139 | 271 | 23 | 36417873 | |
| Pubmed | Misexpression of MIA disrupts lung morphogenesis and causes neonatal death. | 3.80e-05 | 9 | 271 | 3 | 18342301 | |
| Pubmed | 3.80e-05 | 9 | 271 | 3 | 11118901 | ||
| Pubmed | 3.80e-05 | 9 | 271 | 3 | 16245338 | ||
| Pubmed | Reshuffling genomic landscapes to study the regulatory evolution of Hox gene clusters. | 3.80e-05 | 9 | 271 | 3 | 21670281 | |
| Pubmed | 3.80e-05 | 9 | 271 | 3 | 28705793 | ||
| Pubmed | 3.80e-05 | 9 | 271 | 3 | 10428862 | ||
| Interaction | RGPD4 interactions | 1.00e-08 | 22 | 269 | 7 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 4.94e-08 | 27 | 269 | 7 | int:RGPD2 | |
| Interaction | RGPD1 interactions | 2.55e-07 | 49 | 269 | 8 | int:RGPD1 | |
| Interaction | RGPD8 interactions | 6.10e-07 | 74 | 269 | 9 | int:RGPD8 | |
| Interaction | LAG3 interactions | 2.22e-06 | 17 | 269 | 5 | int:LAG3 | |
| Interaction | TNK2 interactions | ZBTB16 NEDD4 NLGN3 TJP2 LRRC7 ALK MAPK8IP1 ARHGAP23 MAGI3 SRGAP2 BCAR1 ARVCF EP300 | 2.32e-06 | 195 | 269 | 13 | int:TNK2 |
| Interaction | RGPD3 interactions | 2.78e-06 | 47 | 269 | 7 | int:RGPD3 | |
| Interaction | NPIPB6 interactions | 3.03e-06 | 18 | 269 | 5 | int:NPIPB6 | |
| Interaction | NXPH2 interactions | 4.38e-06 | 33 | 269 | 6 | int:NXPH2 | |
| Interaction | CTAGE1 interactions | 6.12e-06 | 10 | 269 | 4 | int:CTAGE1 | |
| Interaction | PCDHGB1 interactions | 8.62e-06 | 77 | 269 | 8 | int:PCDHGB1 | |
| Interaction | SIRPD interactions | HLA-DQB1 TMEM132A LAMB2 GALNT12 CELSR1 CELSR2 ADAMTS7 TMEM131 | 1.96e-05 | 86 | 269 | 8 | int:SIRPD |
| Interaction | LOC254896 interactions | 2.15e-05 | 43 | 269 | 6 | int:LOC254896 | |
| Interaction | CEACAM8 interactions | CEACAM8 CEACAM6 BCKDHB ADGRV1 NRP2 FREM2 PTPRS TMEM132A GALNT12 | 3.17e-05 | 119 | 269 | 9 | int:CEACAM8 |
| Interaction | RGPD5 interactions | 4.37e-05 | 96 | 269 | 8 | int:RGPD5 | |
| Interaction | CBL interactions | SPRY1 TSC2 NEDD4 FER TJP2 FGFR2 GNAS CHCHD2P9 HSPA1L ALK NOTCH3 SYNM SH3BP2 BCAR1 CBR1 SNX18 CHCHD2 TNFRSF1A EP300 | 7.01e-05 | 516 | 269 | 19 | int:CBL |
| Cytoband | 5q31 | 6.71e-05 | 115 | 272 | 6 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 8.06e-05 | 298 | 272 | 9 | chr5q31 | |
| Cytoband | 7q35 | 3.24e-04 | 55 | 272 | 4 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 6.51e-04 | 66 | 272 | 4 | chr7q35 | |
| Cytoband | 2q13 | 7.29e-04 | 68 | 272 | 4 | 2q13 | |
| GeneFamily | CTAGE family | 3.72e-07 | 15 | 194 | 5 | 907 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | CEACAM5 FSTL5 FSTL4 MDGA2 PTPRS FGFR2 MYOM3 HMCN1 KIRREL1 ROBO1 MYOM2 | 1.34e-06 | 161 | 194 | 11 | 593 |
| GeneFamily | Cas scaffolding proteins | 4.83e-06 | 4 | 194 | 3 | 469 | |
| GeneFamily | Ankyrin repeat domain containing|Death associated protein kinases | 1.20e-05 | 5 | 194 | 3 | 1021 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | PRKD3 ARHGAP22 PLEKHA7 ARAP1 RASA1 ARHGAP23 SH3BP2 ARHGEF18 PLEKHA6 ARAP3 PLEKHG6 | 1.44e-05 | 206 | 194 | 11 | 682 |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 2.11e-05 | 16 | 194 | 4 | 14 | |
| GeneFamily | PDZ domain containing | 3.92e-05 | 152 | 194 | 9 | 1220 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 1.15e-04 | 24 | 194 | 4 | 654 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.42e-04 | 115 | 194 | 7 | 769 | |
| GeneFamily | Immunoglobulin like domain containing | CEACAM5 CEACAM8 FSTL4 CEACAM6 MDGA2 MYOM3 FCRLB KIRREL1 MYOM2 | 2.43e-04 | 193 | 194 | 9 | 594 |
| GeneFamily | Fibronectin type III domain containing | 3.38e-04 | 160 | 194 | 8 | 555 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 3.41e-04 | 3 | 194 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 3.41e-04 | 3 | 194 | 2 | 1189 | |
| GeneFamily | Cadherin related | 7.40e-04 | 17 | 194 | 3 | 24 | |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 1.12e-03 | 5 | 194 | 2 | 1182 | |
| GeneFamily | Ferlin family | 1.67e-03 | 6 | 194 | 2 | 828 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 1.84e-03 | 23 | 194 | 3 | 1288 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 2.01e-03 | 50 | 194 | 4 | 721 | |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 2.09e-03 | 24 | 194 | 3 | 906 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 2.64e-03 | 26 | 194 | 3 | 904 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 3.07e-03 | 8 | 194 | 2 | 658 | |
| GeneFamily | Clustered protocadherins | 4.94e-03 | 64 | 194 | 4 | 20 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 3.97e-08 | 33 | 271 | 7 | MM477 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MYT1L GALNT15 FRMPD4 CRIM1 MDGA2 TSC2 CSMD2 CASZ1 NRP2 NUAK1 TCERG1 SRGAP3 BOD1L1 CACNA1G LRRC7 NNAT SYT13 ADGRL3 AGTPBP1 ARHGAP23 MAGI3 GALNT12 PLEKHA6 MED13L KIFC2 FRY SHANK2 PAK3 ROBO1 GRIP2 CDH4 AHNAK2 | 1.66e-07 | 1106 | 271 | 32 | M39071 |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 2.74e-07 | 43 | 271 | 7 | MM3857 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | FSTL4 BCKDHB MAP3K4 VWA3B BOD1L1 POLG SRGAP2 FRY HMCN1 TTLL4 | 9.55e-06 | 166 | 271 | 10 | M6826 |
| Coexpression | CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS | 1.25e-05 | 50 | 271 | 6 | M1702 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | MYT1L MDGA2 CASZ1 NUAK1 TCERG1 CACNA1G NNAT SYT13 FSD2 PLEKHA6 FRY SHANK2 PAK3 ROBO1 GRIP2 CDH4 | 3.08e-05 | 465 | 271 | 16 | M39066 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PHF20 CRIM1 DAPK1 ZEB2 MAP3K4 NEDD4 PJA2 NUAK1 MID1 TJP2 RANBP2 DMXL2 IPO7 RASA1 MAP3K14 SPAG9 SRGAP2 MED13L MYOF FAM193A CDK13 RBM6 TMEM131 | 3.19e-05 | 856 | 271 | 23 | M4500 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | ATG2A NOTCH3 B4GAT1 SYNM ESYT1 POLG LAMB2 SRGAP2 CBR1 CELSR2 MYOM2 EP300 | 3.35e-05 | 276 | 271 | 12 | M3063 |
| Coexpression | LEE_BMP2_TARGETS_UP | GALNT15 ZBTB16 PIGP RAMP1 CYP2D7 EFS DAPK1 PRKD3 SULT1A3 STARD9 JAG1 TJP2 NNAT NOTCH3 SULT1A4 NKD2 DCHS1 SLC5A8 REPS2 TNXB HDC AHNAK2 | 3.70e-05 | 805 | 271 | 22 | MM1067 |
| Coexpression | GSE3982_MAC_VS_NKCELL_UP | 4.55e-05 | 199 | 271 | 10 | M5508 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | MYT1L FRMPD4 MDGA2 CSMD2 CASZ1 SORCS1 NUAK1 CACNA1G LRRC7 NNAT SYT13 PLEKHA6 KIFC2 FRY SHANK2 PAK3 KIRREL1 ROBO1 GRIP2 CDH4 | 4.85e-05 | 703 | 271 | 20 | M39070 |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | PTPRS C3 DLG4 MAPK8IP1 SYNM LAMB2 TRIM10 MYOF HMCN1 TTLL4 DCHS1 TNXB | 8.57e-10 | 174 | 272 | 12 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 MDGA2 ADGRV1 PKD1L2 SORCS1 FREM2 DISP3 ADGRL3 FIGN HMCN1 ROBO1 MYOM2 | 1.62e-09 | 184 | 272 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 MDGA2 ADGRV1 PKD1L2 SORCS1 FREM2 DISP3 ADGRL3 FIGN HMCN1 ROBO1 MYOM2 | 1.62e-09 | 184 | 272 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 MDGA2 ADGRV1 PKD1L2 SORCS1 FREM2 DISP3 ADGRL3 FIGN HMCN1 ROBO1 MYOM2 | 1.62e-09 | 184 | 272 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DAPK2 DAPK1 ADGRV1 FREM2 C3 FGFR2 PLEKHA7 MAGI3 FIGN CELSR1 SHANK2 | 2.05e-08 | 185 | 272 | 11 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DAPK2 DAPK1 ADGRV1 FREM2 FGFR2 PLEKHA7 MAGI3 CELSR1 SHANK2 MAP3K13 REPS2 | 4.33e-08 | 199 | 272 | 11 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 |
| ToppCell | mLN-(5)_Dendritic_cell-(54)_pDC|mLN / shred on region, Cell_type, and subtype | LGMN TIFAB MAP1A LILRB2 CDH23 DAPK1 NME8 PTPRS NKD2 REPS2 FUT7 | 4.33e-08 | 199 | 272 | 11 | 1e738219784a446ee8b0ddeb408e0050e1929e60 |
| ToppCell | mLN-Dendritic_cell-pDC|mLN / Region, Cell class and subclass | LGMN TIFAB MAP1A LILRB2 CDH23 DAPK1 NME8 PTPRS NKD2 REPS2 FUT7 | 4.33e-08 | 199 | 272 | 11 | 54f1abb57af7bf8a8b82a38b933f257df3b5d8df |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | LILRB2 BCL6 PPP1R15A ZEB2 ARAP1 DMXL2 LILRB3 SH3BP2 SRGAP2 MED13L MYOF | 4.56e-08 | 200 | 272 | 11 | 934c2efc780318c66d667ca75be0de350361d351 |
| ToppCell | mild-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | LILRB2 CDH23 DAPK1 C3 ARAP1 AMPD2 DMXL2 LILRB3 SH3BP2 MYOF SNX18 | 4.56e-08 | 200 | 272 | 11 | 334bab6bf93d455f3526e817ea5785d8b6ee531c |
| ToppCell | (54)_pDC|World / shred on Cell_type and subtype | LGMN TIFAB MAP1A LILRB2 CDH23 DAPK1 NME8 NLGN3 NKD2 REPS2 FUT7 | 5.31e-08 | 203 | 272 | 11 | b8ba3e51770ff7b45cd02472f3e63aa4d5816f6f |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-07 | 178 | 272 | 10 | ccd37575b60102f5e647c01546e8ff8fec638bd7 | |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-07 | 178 | 272 | 10 | 87b04753650e45f12299c8456fb980d6c0d5961c | |
| ToppCell | facs-Lung-18m-Endothelial-venous_endothelial-vein_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-07 | 178 | 272 | 10 | ebfae386a518ea33911ba3ff40464c94d18ef695 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | BCL6 HOXC11 HOXD10 JAG1 ADGRL3 NOTCH3 SYNM FRY KIRREL1 MYOM2 | 1.63e-07 | 179 | 272 | 10 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DAPK2 DAPK1 ADGRV1 C3 FGFR2 PLEKHA7 MAGI3 KIFC2 CELSR1 SHANK2 | 2.44e-07 | 187 | 272 | 10 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.44e-07 | 187 | 272 | 10 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-07 | 188 | 272 | 10 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | DAPK2 CEACAM6 ADGRV1 CASZ1 FGFR2 PLEKHA7 MAGI3 CELSR1 SHANK2 MAP3K13 | 2.56e-07 | 188 | 272 | 10 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-07 | 188 | 272 | 10 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | DAPK2 DAPK1 ADGRV1 FAAH C3 PLEKHA7 MAGI3 KIFC2 CELSR1 SHANK2 | 3.95e-07 | 197 | 272 | 10 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.95e-07 | 197 | 272 | 10 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DAPK2 DAPK1 ADGRV1 SRGAP3 FGFR2 PLEKHA7 NOTCH3 MAGI3 CELSR1 SHANK2 | 4.13e-07 | 198 | 272 | 10 | 1408e02e053ad3406229bfe8189da03be6366e81 |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|World / disease group, cell group and cell class | LILRB2 CDH23 ARAP1 AMPD2 DMXL2 LILRB3 SH3BP2 MYOF NSMF SNX18 | 4.13e-07 | 198 | 272 | 10 | 8449934e20bb2a34079fb642cae0d4647b9efe51 |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DAPK2 DAPK1 ADGRV1 FREM2 FGFR2 PLEKHA7 MAGI3 CELSR1 SHANK2 MAP3K13 | 4.33e-07 | 199 | 272 | 10 | 5f7da3eab58ace6cddb3179a415cd839d5767958 |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ADGRV1 CASZ1 SRGAP3 MID1 PLEKHA7 RALGAPA2 KIAA1671 CELSR1 SHANK2 MAP3K13 | 4.53e-07 | 200 | 272 | 10 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DAPK1 BCKDHB ADGRV1 CASZ1 PLEKHA7 GALNT12 FIGN RALGAPA2 SHANK2 MAP3K13 | 4.53e-07 | 200 | 272 | 10 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 1.07e-06 | 170 | 272 | 9 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-06 | 130 | 272 | 8 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-06 | 176 | 272 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-06 | 179 | 272 | 9 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.64e-06 | 179 | 272 | 9 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TIFAB ZEB2 NRP2 ARHGAP22 NLGN3 CACNA1G PRUNE2 MAP3K6 KIRREL1 | 1.96e-06 | 183 | 272 | 9 | ad7421623e4c0c5ba02eec56e9bdae43ebb88d90 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-06 | 185 | 272 | 9 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-06 | 185 | 272 | 9 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.25e-06 | 186 | 272 | 9 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | ZBTB16 CYP27B1 SORCS1 PLEKHA7 PRUNE2 SH3BP2 PLEKHA6 KIAA1671 CELSR1 | 2.35e-06 | 187 | 272 | 9 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 |
| ToppCell | COVID-19_Mild-Neu_2|World / 5 Neutrophil clusters in COVID-19 patients | 2.41e-06 | 140 | 272 | 8 | b1429028c52f84127b894b93b55961badcd5246f | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-06 | 188 | 272 | 9 | ec0e241de2c8310b4417b9d4e2420d7a1662f1c0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | DAPK1 NEDD9 SRGAP3 ADGRL3 PRUNE2 CELSR1 SHANK2 KIRREL1 NEK11 | 2.45e-06 | 188 | 272 | 9 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-06 | 189 | 272 | 9 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.56e-06 | 189 | 272 | 9 | 63449d9f1e78ff2bc8786eb88a0d177fe30c7f4d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.68e-06 | 190 | 272 | 9 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | IPF-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | ZBTB16 LILRB2 CDH23 ZEB2 NEDD9 AGTPBP1 ARHGEF18 SRGAP2 SNX18 | 2.68e-06 | 190 | 272 | 9 | f9c2a13c7f6460e3b348581be855b7281c8f70b5 |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.68e-06 | 190 | 272 | 9 | e102622f05c7f3e1bd8b224ea159d57033793ee0 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.79e-06 | 191 | 272 | 9 | de2cd94ee88a7754f86d39469e38374d668210c7 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 2.79e-06 | 191 | 272 | 9 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 2.79e-06 | 191 | 272 | 9 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 2.79e-06 | 191 | 272 | 9 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.83e-06 | 143 | 272 | 8 | 9836a040a2ebcf6f05431e658a7b8fd566621452 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.83e-06 | 143 | 272 | 8 | 4622c221b5d2d4cd4f37e4f81662e073924e1507 | |
| ToppCell | IPF-Myeloid-ncMonocyte|IPF / Disease state, Lineage and Cell class | ZBTB16 LILRB2 CDH23 ZEB2 NEDD9 AGTPBP1 ARHGEF18 SRGAP2 SNX18 | 2.91e-06 | 192 | 272 | 9 | e9fb8c57d8094f70fb492909b2bec40aa5f2e5b8 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.91e-06 | 192 | 272 | 9 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-06 | 193 | 272 | 9 | 5260ac95a15cc43a19909badad0c7e3854da920d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.04e-06 | 193 | 272 | 9 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-06 | 193 | 272 | 9 | 5ec917931b438dd0e7fb03eb6af459d3ef6b84ba | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.04e-06 | 193 | 272 | 9 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | healthy_donor-Myeloid-Monocytic-CD16+_Monocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.17e-06 | 194 | 272 | 9 | ecf746ef1c5c4d6d9ca06a6d3e3778670b5700c2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-06 | 195 | 272 | 9 | 5dc874641ad9537e4c1369825c1fb0a59f12a83d | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | LGMN CRIM1 DAPK2 NRP2 ARHGAP23 RALGAPA2 KIAA1671 ARAP3 HMCN1 | 3.31e-06 | 195 | 272 | 9 | 6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 3.45e-06 | 196 | 272 | 9 | 256c557fa11414c9d2cbb1fcff33f482ee1c78ac | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class | 3.45e-06 | 196 | 272 | 9 | af9e8f5ef9d03862f707e105857309b55595b1b9 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-06 | 196 | 272 | 9 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 3.45e-06 | 196 | 272 | 9 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|World / disease group, cell group and cell class | 3.60e-06 | 197 | 272 | 9 | 60fee75b12451206bb2c07b61651a73c59ec6ade | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Transverse / Region, Cell class and subclass | 3.60e-06 | 197 | 272 | 9 | a58af0ea82f76f2a7abac1f62629ff20d552fc63 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.60e-06 | 197 | 272 | 9 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.60e-06 | 197 | 272 | 9 | e698a0bbb20bd4868ff4348f2ac9f609942b55fa | |
| ToppCell | Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC|Transverse / shred on region, Cell_type, and subtype | 3.60e-06 | 197 | 272 | 9 | 15b87fd3906d7388c271d30d0c64b1bcc490801c | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.75e-06 | 198 | 272 | 9 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.75e-06 | 198 | 272 | 9 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-06 | 198 | 272 | 9 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.75e-06 | 198 | 272 | 9 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.90e-06 | 199 | 272 | 9 | f1b370d2869ad29c9d8ff41fdcc486fffa781ee2 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-06 | 199 | 272 | 9 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.90e-06 | 199 | 272 | 9 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.07e-06 | 200 | 272 | 9 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.07e-06 | 200 | 272 | 9 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 4.07e-06 | 200 | 272 | 9 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.07e-06 | 200 | 272 | 9 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1-SPP1+|Mild / Condition, Lineage, Cell class and cell subclass | 4.07e-06 | 200 | 272 | 9 | e5afd8e2cb2c63899d49fe17011f474d20bb06ea | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-06 | 157 | 272 | 8 | c762b03e254c73222094725ca8ac1c8eb428bccb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-06 | 157 | 272 | 8 | 7fdc0094dd5729990a91a30c1982a14c74650b52 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-06 | 157 | 272 | 8 | 6b5b08bb5520fcf6f4c0560f7ed7645ec179806d | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 6.21e-06 | 159 | 272 | 8 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.50e-06 | 160 | 272 | 8 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | CV-Healthy-3|CV / Virus stimulation, Condition and Cluster | 6.80e-06 | 161 | 272 | 8 | fd4a79385ea967b9900dc76a3add813b894a3a28 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.90e-06 | 167 | 272 | 8 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 8.90e-06 | 167 | 272 | 8 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 8.90e-06 | 167 | 272 | 8 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 9.29e-06 | 168 | 272 | 8 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-05 | 170 | 272 | 8 | 4a19c7e3bb0f9c2601a10debe7000066789b4150 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 170 | 272 | 8 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-05 | 170 | 272 | 8 | 439167e44a1bd5ac8e1e457351dd202ec968db46 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 170 | 272 | 8 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-05 | 170 | 272 | 8 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.10e-05 | 172 | 272 | 8 | 980e8b9e1ceeb0dec9eb9ef95c139e5ffe99b6e4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 173 | 272 | 8 | ab6d3507301038f944ad59ccd848b5e6eeb76d04 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.20e-05 | 174 | 272 | 8 | 8393f0b43c767839c1630bcb952d62b42efc788d | |
| ToppCell | COVID-19-APC-like-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 1.25e-05 | 126 | 272 | 7 | 9f94291b1db020cc0ebf9c8de4e01bd883295672 | |
| Drug | (+/-)-thalidomide; Up 200; 100uM; MCF7; HG-U133A | TSC2 DHX8 PRKD3 TJP2 FGFR2 WDR13 ARAP1 SH3BP2 EBLN2 GALNT12 TESK1 TRMT2A TTLL4 SLC24A1 | 9.45e-08 | 198 | 266 | 14 | 266_UP |
| Drug | Methylcholanthrene | GALNT15 PIGP PHF20 DAPK2 DAPK1 BCL6 NEDD9 PRKD3 ARHGAP22 FREM2 HOXC11 ALDH1L2 JAG1 MID1 C3 CACNA1G FGFR2 ARRDC3 RGPD5 RANBP2 EXOSC9 SYNM PLEKHA6 MED13L RALGAPA2 CBR1 MYOF NKD2 CHCHD2 ROBO1 MYOM2 | 1.59e-06 | 1034 | 266 | 31 | ctd:D008748 |
| Drug | Linuron | MDGA2 TSC2 DLG4 CACNA1G LRRC7 FGFR2 NOTCH3 SHANK2 ROBO1 MYOM2 | 2.71e-06 | 128 | 266 | 10 | ctd:D008044 |
| Drug | Pregnenolone [145-13-1]; Up 200; 12.6uM; MCF7; HT_HG-U133A | BCL6 PTPRS JAG1 NFKBIB MID1 C3 DMXL2 SH3BP2 MYOF YIF1B CELSR2 | 1.34e-05 | 187 | 266 | 11 | 2856_UP |
| Drug | procymidone | 1.49e-05 | 155 | 266 | 10 | ctd:C035988 | |
| Drug | butylparaben | 1.66e-05 | 157 | 266 | 10 | ctd:C038091 | |
| Drug | Iopromide [73334-07-3]; Down 200; 5uM; HL60; HT_HG-U133A | PHF20 CRIM1 LILRB2 PPP1R15A NFKBIB NNAT POLG DIDO1 PQBP1 NOX1 DCAF11 | 1.88e-05 | 194 | 266 | 11 | 2739_DN |
| Drug | Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | ARID1A NRP2 NEDD9 NFKBIB DMXL2 EBLN2 PLA2G4C ARVCF CDK13 TTLL4 AHNAK2 | 2.17e-05 | 197 | 266 | 11 | 3399_DN |
| Drug | Memantine Hydrochloride [41100-52-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A | FSTL4 CLIC2 PTPRS NFKBIB MID1 C3 ARAP1 SH3BP2 DCHS1 MYOM2 AHNAK2 | 2.17e-05 | 197 | 266 | 11 | 4135_UP |
| Drug | Ioversol [87771-40-2]; Up 200; 5uM; MCF7; HT_HG-U133A | MAP1A CEACAM6 FAAH FGFR2 NMT1 LAMB2 PIP5K1C SHANK2 ARVCF SLC24A1 NEK11 | 2.28e-05 | 198 | 266 | 11 | 5326_UP |
| Drug | Benzathine benzylpenicillin [5928-84-7]; Up 200; 4.2uM; MCF7; HT_HG-U133A | SPRY1 DAPK3 BCL6 NFKBIB ARAP1 SH3BP2 GALNT12 PLEKHA6 SHANK2 ARVCF AHNAK2 | 2.38e-05 | 199 | 266 | 11 | 4140_UP |
| Disease | Malignant neoplasm of breast | HAPLN4 ARID1A ZEB2 NME8 FAAH NEDD4 SORCS1 SRGAP3 JAG1 BOD1L1 LRRC7 FGFR2 ARRDC3 ALK NOTCH3 B4GAT1 BCAR1 MAP3K6 TESK1 EPG5 ARAP3 TRMT2A ROBO1 MAP3K13 REPS2 EP300 | 1.73e-06 | 1074 | 250 | 26 | C0006142 |
| Disease | Dupuytren Contracture | 4.03e-06 | 108 | 250 | 8 | EFO_0004229 | |
| Disease | Intellectual Disability | MYT1L UBA5 PIGP FRMPD4 SRGAP3 UGP2 DLG4 CACNA1G FGFR2 GNAS MED13L PQBP1 FRY SHANK2 | 3.16e-05 | 447 | 250 | 14 | C3714756 |
| Disease | Ovarian Serous Adenocarcinoma | 3.92e-05 | 23 | 250 | 4 | C1335177 | |
| Disease | Pierson syndrome (implicated_via_orthology) | 7.15e-05 | 2 | 250 | 2 | DOID:0060852 (implicated_via_orthology) | |
| Disease | BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1 | 7.15e-05 | 2 | 250 | 2 | C2751544 | |
| Disease | Granuloma, Plasma Cell | 7.15e-05 | 2 | 250 | 2 | C0018199 | |
| Disease | Profound Mental Retardation | 1.90e-04 | 139 | 250 | 7 | C0020796 | |
| Disease | Mental deficiency | 1.90e-04 | 139 | 250 | 7 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 1.90e-04 | 139 | 250 | 7 | C0025363 | |
| Disease | Spinocerebellar Ataxia Type 2 | 1.91e-04 | 34 | 250 | 4 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 1.91e-04 | 34 | 250 | 4 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 1.91e-04 | 34 | 250 | 4 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 1.91e-04 | 34 | 250 | 4 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 1.91e-04 | 34 | 250 | 4 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 1.91e-04 | 34 | 250 | 4 | C0087012 | |
| Disease | frontotemporal dementia and/or amyotrophic lateral sclerosis-2 (implicated_via_orthology) | 2.13e-04 | 3 | 250 | 2 | DOID:0060214 (implicated_via_orthology) | |
| Disease | spinal muscular atrophy, Jokela type (implicated_via_orthology) | 2.13e-04 | 3 | 250 | 2 | DOID:0081356 (implicated_via_orthology) | |
| Disease | Parkinson's disease 22 (implicated_via_orthology) | 2.13e-04 | 3 | 250 | 2 | DOID:0080504 (implicated_via_orthology) | |
| Disease | Spinocerebellar Ataxia Type 4 | 2.14e-04 | 35 | 250 | 4 | C0752122 | |
| Disease | Sclerocystic Ovaries | 2.36e-04 | 144 | 250 | 7 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 2.36e-04 | 144 | 250 | 7 | C0032460 | |
| Disease | T-Cell Lymphoma | 3.10e-04 | 16 | 250 | 3 | C0079772 | |
| Disease | FEV/FEC ratio | CRIM1 IP6K3 HLA-DQB1 CDH23 PTCH1 ZEB2 NRP2 FREM2 SRGAP3 FGFR2 TAF7 ARAP1 SH3BP2 ARHGEF18 GALNT12 SRGAP2 FAM83H HMCN1 ARVCF CEP72 LRRC37B TNXB HDC | 3.41e-04 | 1228 | 250 | 23 | EFO_0004713 |
| Disease | Colorectal Carcinoma | TRPM7 EFS FSTL5 ARID1A ZEB2 PTPRS NPAP1 GNAS AGTPBP1 AKAP3 GALNT12 PQBP1 ARAP3 DCHS1 EP300 HDC | 3.55e-04 | 702 | 250 | 16 | C0009402 |
| Disease | BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1 | 4.24e-04 | 4 | 250 | 2 | 605462 | |
| Disease | silicosis (is_implicated_in) | 4.24e-04 | 4 | 250 | 2 | DOID:10325 (is_implicated_in) | |
| Disease | Basal cell carcinoma, susceptibility to, 1 | 4.24e-04 | 4 | 250 | 2 | cv:C2751544 | |
| Disease | coronary artery disease | GALNT15 ANKRD31 TRPM7 HLA-DQB1 ZEB2 NEDD4 NEDD9 FER LRRC7 PLEKHA7 ALK ADGRL3 LAMB2 MAGI3 BCAR1 FIGN EPG5 CELSR2 ADAMTS7 ARVCF ELFN1 TNXB | 5.70e-04 | 1194 | 250 | 22 | EFO_0001645 |
| Disease | interleukin 13 measurement | 5.71e-04 | 45 | 250 | 4 | EFO_0008171 | |
| Disease | Schizophrenia | MYT1L HLA-DQB1 CSMD2 SRGAP3 JAG1 DLG4 FGFR2 GNAS HSPA1L ALK PLEKHA6 PTPN21 TRMT2A PLA2G4C WDR11 ARVCF TNFRSF1A TNXB | 5.79e-04 | 883 | 250 | 18 | C0036341 |
| Disease | Neuroblastoma | 6.74e-04 | 47 | 250 | 4 | C0027819 | |
| Disease | Atrial Septal Defects | 7.03e-04 | 5 | 250 | 2 | C0018817 | |
| Disease | Endometrioid carcinoma ovary | 7.03e-04 | 5 | 250 | 2 | C0346163 | |
| Disease | sex interaction measurement, cerebral amyloid angiopathy | 7.14e-04 | 21 | 250 | 3 | EFO_0006790, EFO_0008343 | |
| Disease | myocardial infarction | ANKRD31 ZEB2 ADGRL3 LAMB2 MAGI3 BCAR1 FIGN CELSR2 ELFN1 SNX18 | 8.66e-04 | 350 | 250 | 10 | EFO_0000612 |
| Disease | allergic bronchopulmonary aspergillosis (is_implicated_in) | 1.05e-03 | 6 | 250 | 2 | DOID:13166 (is_implicated_in) | |
| Disease | paroxysmal nocturnal hemoglobinuria (is_implicated_in) | 1.05e-03 | 6 | 250 | 2 | DOID:0060284 (is_implicated_in) | |
| Disease | pneumocystosis (biomarker_via_orthology) | 1.05e-03 | 6 | 250 | 2 | DOID:11339 (biomarker_via_orthology) | |
| Disease | Inflammatory Myofibroblastic Tumor | 1.05e-03 | 6 | 250 | 2 | C0334121 | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.07e-03 | 24 | 250 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.07e-03 | 24 | 250 | 3 | C3805278 | |
| Disease | mental development measurement | 1.20e-03 | 25 | 250 | 3 | EFO_0008230 | |
| Disease | mean arterial pressure | DAPK1 CASZ1 PRKD3 GNAS NMT1 PLEKHA7 LINC02875 TNS2 BCAR1 FIGN ARAP3 ROBO1 | 1.22e-03 | 499 | 250 | 12 | EFO_0006340 |
| Disease | hip bone mineral density, hip bone size | 1.31e-03 | 56 | 250 | 4 | EFO_0004844, EFO_0007702 | |
| Disease | Cholangiocarcinoma | 1.35e-03 | 26 | 250 | 3 | C0206698 | |
| Disease | nephrosis (implicated_via_orthology) | 1.46e-03 | 7 | 250 | 2 | DOID:2527 (implicated_via_orthology) | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 1.46e-03 | 7 | 250 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | group XIIB secretory phospholipase A2-like protein measurement | 1.46e-03 | 7 | 250 | 2 | EFO_0801657 | |
| Disease | Pituitary stalk interruption syndrome | 1.46e-03 | 7 | 250 | 2 | C4053775 | |
| Disease | Endometrial Neoplasms | 1.49e-03 | 58 | 250 | 4 | C0014170 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 1.51e-03 | 27 | 250 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | photoreceptor cell layer thickness measurement | 1.69e-03 | 148 | 250 | 6 | EFO_0803370 | |
| Disease | coronary artery calcification | MYT1L RAMP1 FSTL5 FSTL4 STARD9 CHCHD2P9 DMXL2 MED13L FRY ADAMTS7 CDH4 | 1.70e-03 | 450 | 250 | 11 | EFO_0004723 |
| Disease | pulmonary tuberculosis | 1.87e-03 | 29 | 250 | 3 | EFO_1000049 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.93e-03 | 152 | 250 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | renin measurement | 1.94e-03 | 8 | 250 | 2 | EFO_0010616 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 1.94e-03 | 8 | 250 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | gdnf family receptor alpha-1 measurement | 1.94e-03 | 8 | 250 | 2 | EFO_0020400 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 2.06e-03 | 30 | 250 | 3 | EFO_0000341, EFO_0004351 | |
| Disease | Non-Small Cell Lung Carcinoma | 2.20e-03 | 156 | 250 | 6 | C0007131 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 2.27e-03 | 157 | 250 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | hip bone size | 2.27e-03 | 65 | 250 | 4 | EFO_0004844 | |
| Disease | Breast Carcinoma | HAPLN4 ARID1A ZEB2 JAG1 FGFR2 ARRDC3 ALK NOTCH3 B4GAT1 MAP3K13 REPS2 EP300 | 2.28e-03 | 538 | 250 | 12 | C0678222 |
| Disease | Disorder of eye | 2.29e-03 | 212 | 250 | 7 | C0015397 | |
| Disease | estrogen-receptor positive breast cancer | 2.47e-03 | 9 | 250 | 2 | EFO_1000649 | |
| Disease | Dermatitis, Irritant | 2.47e-03 | 9 | 250 | 2 | C0162823 | |
| Disease | Seizures | 2.68e-03 | 218 | 250 | 7 | C0036572 | |
| Disease | colorectal adenoma | 2.72e-03 | 33 | 250 | 3 | EFO_0005406 | |
| Disease | peptic ulcer disease | 2.72e-03 | 33 | 250 | 3 | MONDO_0004247 | |
| Disease | Brain Tumor, Primary | 2.72e-03 | 33 | 250 | 3 | C0750974 | |
| Disease | Primary malignant neoplasm of brain | 2.72e-03 | 33 | 250 | 3 | C0750979 | |
| Disease | Recurrent Brain Neoplasm | 2.72e-03 | 33 | 250 | 3 | C0750977 | |
| Disease | Benign neoplasm of brain, unspecified | 2.72e-03 | 33 | 250 | 3 | C0496899 | |
| Disease | Neoplasms, Intracranial | 2.72e-03 | 33 | 250 | 3 | C1527390 | |
| Disease | response to ketamine | 2.83e-03 | 69 | 250 | 4 | EFO_0009748 | |
| Disease | stroke outcome severity measurement | 2.91e-03 | 114 | 250 | 5 | EFO_0009603 | |
| Disease | fish oil supplement exposure measurement, triglyceride measurement | 3.08e-03 | 10 | 250 | 2 | EFO_0004530, EFO_0600007 | |
| Disease | CCL19 measurement | 3.08e-03 | 10 | 250 | 2 | EFO_0009415 | |
| Disease | coronary aneurysm | 3.22e-03 | 35 | 250 | 3 | EFO_1000881 | |
| Disease | platelet crit | ANKRD31 ZBTB16 IP6K3 MAP1A ADGRV1 ARID1A NMT1 NOTCH3 MAP3K14 PLEKHA6 MLYCD EPG5 ARVCF PRPF3 CDK13 DCHS1 TNFRSF1A | 3.29e-03 | 952 | 250 | 17 | EFO_0007985 |
| Disease | Endometrial Carcinoma | 3.30e-03 | 72 | 250 | 4 | C0476089 | |
| Disease | multiple sclerosis (is_implicated_in) | 3.47e-03 | 73 | 250 | 4 | DOID:2377 (is_implicated_in) | |
| Disease | cAMP-specific 3',5'-cyclic phosphodiesterase 4D measurement | 3.74e-03 | 11 | 250 | 2 | EFO_0020224 | |
| Disease | Basal cell carcinoma | 3.74e-03 | 11 | 250 | 2 | C0007117 | |
| Disease | polymyositis (is_marker_for) | 3.74e-03 | 11 | 250 | 2 | DOID:0080745 (is_marker_for) | |
| Disease | sexual dysfunction | 3.74e-03 | 11 | 250 | 2 | EFO_0004714 | |
| Disease | Hand-foot syndrome, response to fluoropyrimidines | 3.74e-03 | 11 | 250 | 2 | EFO_0010825, EFO_1001893 | |
| Disease | uveitis (implicated_via_orthology) | 3.74e-03 | 11 | 250 | 2 | DOID:13141 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of brain | 4.07e-03 | 38 | 250 | 3 | C0153633 | |
| Disease | Squamous cell carcinoma | 4.17e-03 | 124 | 250 | 5 | C0007137 | |
| Disease | asparaginase hypersensitivity | 4.20e-03 | 77 | 250 | 4 | EFO_0004881 | |
| Disease | S-6-hydroxywarfarin measurement | 4.37e-03 | 368 | 250 | 9 | EFO_0803326 | |
| Disease | Cleft upper lip | 4.39e-03 | 39 | 250 | 3 | C0008924 | |
| Disease | Brain Neoplasms | 4.39e-03 | 39 | 250 | 3 | C0006118 | |
| Disease | monocyte count | CERKL ZBTB16 TRPM7 CDH23 ADGRV1 BCL6 CASZ1 JAG1 C3 SYT13 LILRB3 ARHGAP23 MAP3K14 DIDO1 DOK2 PLEKHA6 MED13L ARVCF FCRLB KIRREL1 TNFRSF1A | 4.40e-03 | 1320 | 250 | 21 | EFO_0005091 |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 4.46e-03 | 12 | 250 | 2 | EFO_0801493 | |
| Disease | microphthalmia (implicated_via_orthology) | 4.46e-03 | 12 | 250 | 2 | DOID:10629 (implicated_via_orthology) | |
| Disease | basal cell carcinoma (is_implicated_in) | 4.46e-03 | 12 | 250 | 2 | DOID:2513 (is_implicated_in) | |
| Disease | granulins measurement | 4.46e-03 | 12 | 250 | 2 | EFO_0008141 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DIYGPRPAVTAPEVI | 81 | Q7L8C5 | |
| TGRPTAEPDPILDNY | 31 | Q8N350 | |
| RPDPPSAAILVVYLD | 471 | Q9BSJ8 | |
| YRQDPESLPFRQPVD | 1066 | Q09472 | |
| YPQLPAEIAGEAPAL | 216 | Q9HCE0 | |
| PEFVAPEIVNYEPLG | 181 | P53355 | |
| YEIRSPEISPGLEVP | 161 | Q6ZSZ5 | |
| GPIPYLDDDIPLLEV | 661 | Q9P2K9 | |
| EAPRFIQEPYVALVP | 131 | Q96JP9 | |
| IQEPYVALVPEDIPA | 136 | Q96JP9 | |
| TEDSYAAEVVGPPRP | 251 | P0C7U0 | |
| PEAVTRIPYLPAAGE | 491 | P0C7U0 | |
| LPSDPSPGVYNEVVV | 661 | Q8WWN8 | |
| PPLVTLLSGEPEVQY | 286 | P63010 | |
| RPAEEQPPFGVYAVI | 581 | Q9UJX6 | |
| VPGADRYQEAEPGPL | 586 | O00192 | |
| LEPCEEPEVPAYSIR | 1036 | Q7Z408 | |
| RPDENPYGFPSELVV | 31 | Q8IX94 | |
| RPDENPYGFPSELVV | 31 | Q86UF2 | |
| RPDENPYGFPSELVV | 31 | P0CG41 | |
| RPDENPYGFPSELVV | 31 | A4FU28 | |
| RPDENPYGFPSELVV | 31 | A4D2H0 | |
| AYDVPRGVQFLEPPA | 316 | Q14511 | |
| RDGVYDVPLHNPPDA | 341 | Q14511 | |
| SRYEAAVPDPREPGE | 161 | O43505 | |
| QDIYDVPPVRGLLPS | 246 | P56945 | |
| VPDGPLLREETYDVP | 316 | P56945 | |
| DSGVYAVPPPAEREA | 406 | P56945 | |
| YSEEPAPTPVLGRIA | 96 | Q86V15 | |
| GQERLYPPGDVDEIP | 151 | Q6P6C2 | |
| PRIPQPEEGATYEGI | 211 | Q3SY69 | |
| PVILNVLYGPDDPTI | 406 | P06731 | |
| SDPVTLNVLYGPDAP | 226 | P31997 | |
| VERPVDISLSPYPTD | 156 | P78314 | |
| EESDAPLLPPRVYST | 1301 | Q9HAR2 | |
| AGEVITAYEVPPPLN | 3921 | Q8WXG9 | |
| VTNPDGSPAYRVPVA | 376 | P01024 | |
| ELPPLYGAEPEASRA | 276 | Q9P209 | |
| GTRDYTEIDSIPPLP | 1416 | Q8TDJ6 | |
| YVIQDPVPQFRIDPD | 826 | Q9NYQ6 | |
| GPPFLPSEDLQERLY | 1196 | Q9HCU4 | |
| PEDVDPQGIYVISAP | 566 | Q9NYJ7 | |
| KPLETRTYEQGPDTP | 276 | Q01433 | |
| PGEYIIIPSTFEPHR | 516 | Q9UMQ6 | |
| GPVAQLYSLPPEVDD | 351 | Q9UPW5 | |
| VPTFPRDYEGPFEVT | 1741 | Q9H251 | |
| DNGSPPRAAEIPVYL | 2376 | Q9H251 | |
| EPARPDITYQEPQGT | 91 | Q9Y6H1 | |
| PPELLLGEERYTPAI | 881 | Q14004 | |
| PLQVDPAPDYLAERS | 241 | P78312 | |
| ERPEAPPSYAEVVTE | 341 | Q96B67 | |
| LDDPVLGYLPPTVIT | 1096 | Q2TAZ0 | |
| IIDFPSVPPGVLYDV | 456 | Q9UKP4 | |
| FDPRRYPQAPEELGT | 521 | A0A1B0GUU1 | |
| PLGPIPARCFDYEIE | 261 | Q14627 | |
| EYVLEPSPVSLPLDR | 156 | Q96I51 | |
| VRDPPGSILYPFIVV | 111 | O60894 | |
| DGQYFEPVVPLPDLV | 2306 | P49792 | |
| VDAYPIKPEAPREDA | 26 | P10082 | |
| ALPVAAAPYPGLVET | 41 | P20936 | |
| PEPEPTVGAECYRRA | 41 | Q8N4Z0 | |
| GQYFEPVVPLPDLVE | 1331 | Q99666 | |
| GQYFEPVVPLPDLVE | 1331 | O14715 | |
| RYPLPEAVDPDVGVN | 151 | Q9Y5G5 | |
| QYGPQTTPRGELVPD | 21 | P49146 | |
| DPLGVQIPEDLSPVY | 921 | O60271 | |
| CIYETLIPIRPADPE | 226 | Q9H8H0 | |
| YAFECKIERGEDPPP | 1101 | O14497 | |
| LRYVSEDAPILPEPN | 1776 | Q8N7Z5 | |
| YPVVPGNSRVPDKDI | 381 | O15528 | |
| QQYSPIPRIEVDGPF | 371 | Q9Y5S8 | |
| AAAEEVPIEPYNIPL | 246 | P21953 | |
| PGYLRAQLPESAPED | 36 | P19113 | |
| PAPGREKEITASPDY | 361 | P21802 | |
| AFDRQLYRPEPLPEV | 471 | Q96JQ0 | |
| VEGEPPYLNENPLRA | 471 | O75914 | |
| GPVDRPVLSNYSDTP | 81 | Q5HY92 | |
| ADPLYDSIEETLPPR | 326 | O60496 | |
| KPGPQDTVERPFYDL | 181 | Q9NZM5 | |
| PGPPTRTRHDEYLEV | 2206 | P78559 | |
| KDGRAAVPYPPTVAD | 846 | Q71F56 | |
| CRGYPLPDDSEDPVV | 491 | Q5TCQ9 | |
| ENPPTSQRIEPRYDI | 721 | Q9BY89 | |
| PVLRLDNAPEPYDVS | 281 | Q8N387 | |
| FLGQVDVPLYPLPTE | 521 | P46934 | |
| GPVEPDKDNIRQEPY | 136 | P30419 | |
| TAAAPEVGPVLRPLY | 46 | Q9Y697 | |
| PPGTQPIARSEVFRY | 41 | Q16517 | |
| PKGEYPPDLFSVEER | 436 | O60721 | |
| VNEPHELPPTDRYGR | 1131 | Q96NW7 | |
| EATEEIYLTPVQRPP | 276 | Q9UQF2 | |
| IYLTPVQRPPDAAEP | 281 | Q9UQF2 | |
| SDPVTLNVLYGPDVP | 226 | P40199 | |
| EGLLIIEAPQVPPYS | 161 | Q9UJY1 | |
| EDPPLYGEILVNGIP | 986 | Q5SZK8 | |
| YSGRLEPSVPSEVEP | 896 | A9Z1Z3 | |
| DELLRRAVPPTPAYE | 41 | O95822 | |
| EEYSPLEGLPPFISL | 76 | Q8N3T1 | |
| LRLREADEDPGVPPY | 746 | Q86UP0 | |
| EAPDTYLAQGPDRTP | 156 | Q15653 | |
| EARTYVLAPEPPTAL | 1201 | O95382 | |
| EVTLYTPEERDPVPL | 171 | Q06265 | |
| RETAPGDISPYTIPE | 71 | O95373 | |
| RYPLPEAIDPDVGVN | 151 | Q9Y5G4 | |
| PGALPVQIRYSIPEE | 26 | Q9Y5G2 | |
| VYEFQEGAPVRPVSP | 441 | Q5QP82 | |
| RLGDRYNPPVDATPD | 86 | Q8TEB1 | |
| YPLDALEPQPSIGDI | 86 | Q6P2I7 | |
| VPVVLGPPRATYEAF | 251 | Q11130 | |
| DTPDIRRFDPIPAQY | 556 | O60462 | |
| DFPYPLRDVRGEPLE | 1621 | Q9UM47 | |
| PEFVAPEIVNYEPLG | 181 | O43293 | |
| TRYGPEGEAVPVAIP | 176 | P54098 | |
| EGDTPSLPERYPKEL | 246 | Q8NG66 | |
| RPLQPEYVALPSEES | 226 | O94806 | |
| EREPPAEPSIYATLA | 581 | Q8N423 | |
| EVIYRVLDPAIPIPD | 216 | P55268 | |
| RLRQVPVPEPDTYNG | 541 | Q96QE4 | |
| YVPGRPATGPTIEEV | 626 | P34931 | |
| VYTISGEPALLPSPE | 101 | Q6X4W1 | |
| GEPPAEPSIYATLAI | 616 | O75022 | |
| PPPEALTLEVQYERD | 291 | Q9NQG6 | |
| IYPEEITPLLPAISG | 186 | Q2PPJ7 | |
| LLVIYDGQEPPERAP | 326 | Q96PC2 | |
| PTPAGEGYAVPVIQR | 416 | Q969F2 | |
| VQYPPAVEPAFLEIR | 536 | Q7Z553 | |
| EPALPSVYLPLGEEN | 821 | Q7Z442 | |
| PVIRVYPESQAREPG | 341 | Q8N475 | |
| NVYVPPSIEGPEREV | 3146 | Q96RW7 | |
| VRYRPLGSEDPEPKE | 656 | Q13332 | |
| YPAERRPVVGAVSVP | 526 | Q16825 | |
| PEVNPLYRADPVDLE | 291 | Q8IV76 | |
| RPEQYGSLDIPSAEP | 736 | O43283 | |
| DPVDYEATRLEGLPP | 36 | O60828 | |
| AAQRIGPYEVLEPPS | 366 | Q3KR16 | |
| VPLPSEILGPVDQYL | 56 | Q9NZ94 | |
| PVEEGTLPYPIFAAI | 161 | Q9UP65 | |
| DGQYFEPVVPLPDLV | 1331 | A6NKT7 | |
| PLRESYDPDVIPLFD | 1291 | Q8NFC6 | |
| VEVYRAVTPLGPPDA | 76 | P01920 | |
| EPARPDIAYQEPQGT | 91 | Q5T1J5 | |
| SAGLTYELVIENPPP | 86 | B1AJZ9 | |
| IPGAVPPAEIYVEED | 206 | B1AJZ9 | |
| GPIEVYLCPEEVQEP | 296 | Q14209 | |
| SEAEGLPYPALAPVV | 46 | O43497 | |
| PELLVGDTQYGPPVD | 171 | Q00532 | |
| PEFVAPEIVNYEPLG | 191 | Q9UIK4 | |
| PPPVVNYEEDARSVT | 396 | P16591 | |
| VNYIPSEERAPGLPN | 1256 | Q14CM0 | |
| PVIRVYPESQAQEPG | 341 | Q6MZW2 | |
| EGQPLRALDLYPEPA | 6 | Q86X59 | |
| VENPEVPVPGYFRLS | 141 | P28358 | |
| YDVPIIVTDSGNPPL | 686 | P55283 | |
| RCPEDSVLIEGYAPP | 186 | Q9NZV1 | |
| TRLQPEEADVPAYPK | 1216 | Q9BTC0 | |
| TVYPELHVPEDRPGF | 431 | Q8IXK2 | |
| PEPGEDPRVTRAKYF | 326 | P63092 | |
| EAPVSSPYSEELPRL | 41 | Q9NQ33 | |
| RPIQPERPAGDSKYD | 71 | Q49MI3 | |
| EDQEVYVVPPPARPC | 96 | O43281 | |
| PRDALEVYDVPPTAL | 141 | O43281 | |
| RPVPGEYSRPTLEVS | 236 | P41182 | |
| EGAETPVYLALLPPD | 246 | P16152 | |
| PPVIVNTDTLEAPGY | 36 | P78352 | |
| EYPAVIVEPVPSARL | 31 | Q15723 | |
| QVPPVREVSYGLEPS | 66 | O43248 | |
| PEPRHDALIPVEGYQ | 201 | P31276 | |
| EGAETPVYLALLPPD | 246 | O75828 | |
| IESGVEPPDRIRPIY | 236 | Q8N7U6 | |
| GPDTAPQAQVRVYEP | 136 | Q8IXV7 | |
| AEREVPLYVNGPPII | 381 | Q96J84 | |
| EEGTYVEPLPPRCLS | 1041 | Q9ULL0 | |
| DGSVQYPVNRPREPC | 216 | Q86UW8 | |
| RAVPSLGYTEDPELP | 246 | Q5BKX5 | |
| DPTVPPLPFREEVYT | 306 | O00519 | |
| APLVDYLPETITPRG | 1621 | Q5TBA9 | |
| ILQVPYAPVFEGEPL | 106 | Q6BAA4 | |
| GPDYVLEITPSCRPD | 341 | Q9BY41 | |
| PQYVTREPPEGSLLD | 71 | Q6ZRV2 | |
| ERVVLEVEYELPPPA | 121 | Q9C0E4 | |
| VENSPSPLPERAIYG | 26 | P57054 | |
| YNEAVRDLLAPGPPE | 531 | Q96AC6 | |
| IEEFLEQTLAPPRYP | 86 | O15247 | |
| EAPIFTIPGRTYPVE | 731 | Q14562 | |
| GPDVPELIILPVYSA | 801 | Q14562 | |
| PPVDNDTPVTLGVYL | 426 | O43395 | |
| EAEPCPFRVAIYVPG | 501 | O75807 | |
| PPPVELGYRVTAEDL | 216 | Q3SYA9 | |
| GQYFEPVVPLPDLVE | 1316 | P0DJD0 | |
| YTLVDREEKPPNGTP | 1176 | P78504 | |
| IPVQEDESPLGAPYV | 176 | Q99558 | |
| APCTELVPRAAEPGY | 571 | Q9UN66 | |
| LDYTGELEPPEPLAR | 971 | Q9BVI0 | |
| PRPVELPEVEYGRLG | 161 | Q693B1 | |
| SSPTEERDEPAYPRG | 1251 | Q9Y6R4 | |
| SGEKPEADRNPPVLY | 586 | Q8ND04 | |
| VFYPEKQEITLPPDG | 936 | Q8ND04 | |
| VSTVDGDLYPPVEEP | 96 | Q15545 | |
| VYVPQDPGLPEEEEI | 816 | P78332 | |
| DGQYFEPVVPLPDLV | 1331 | Q7Z3J3 | |
| PLEGVRPSPQQTEYR | 226 | Q8IZ69 | |
| GVVIKYSEPPEARIP | 241 | Q8TAD8 | |
| IDEEPIYEPGREFVP | 2141 | Q8WUY3 | |
| GVELRPADPPQYQEV | 236 | Q24JP5 | |
| PDRPKAGDTREVPVY | 446 | O15061 | |
| ERDGQYFEPVVPLPD | 1321 | P0DJD1 | |
| SYPTLEDEGRPDLLP | 496 | O60331 | |
| VDENIPRTGVSEYPP | 91 | A1L4K1 | |
| LPSYVISPVAPEDRI | 211 | Q6IQ23 | |
| LRIPAAEPIEYAQFP | 961 | Q13635 | |
| VGIGAQIYPPLPERT | 456 | Q8N695 | |
| YPGPARLPADTVFTI | 96 | Q9UJQ7 | |
| PEIVNGRPYRGPEVD | 221 | O60285 | |
| PGAPPLESVDVRQIY | 261 | Q15562 | |
| AVYEDRPPGSVVPTS | 126 | Q9H1Z4 | |
| VAALPSQAPYDDPRV | 2741 | Q9P2P6 | |
| FDPESGQYVEVLLPP | 906 | E7EW31 | |
| PYTALGTPVNAEPVE | 951 | Q9NZP6 | |
| REEETPAYQGPGIPE | 86 | Q13438 | |
| VLEIGDPEGPLLPYQ | 121 | Q16586 | |
| DPEGPLLPYQAEFLV | 126 | Q16586 | |
| YVRVPFLEVNDPGEP | 76 | P0DMN0 | |
| YVRVPFLEVNDPGEP | 76 | P0DMM9 | |
| QVPGLRSLDEVYPDP | 706 | Q5JTZ9 | |
| RELPEPVVPFARYED | 236 | Q7Z5H3 | |
| LLREYPQPVGEGVPS | 121 | Q9UPX8 | |
| PQPVGEGVPSLEFRY | 126 | Q9UPX8 | |
| YGPLVEEEEKVPVRP | 1401 | Q9UM73 | |
| SPPRLYEDDETPGAL | 636 | O75969 | |
| EGIRPRPQGSSPVYE | 46 | Q8IVF2 | |
| YDEVPEEGPGAPARV | 231 | Q96P48 | |
| NRSIPVEVDESEPYP | 11 | O43734 | |
| TVGDTPPPAREEEYL | 231 | Q8IV77 | |
| EDTADRPPAPIYQVL | 96 | A0A087X1C5 | |
| IVPDPPAQRLYACDE | 261 | Q96EG3 | |
| IPERYIDLEPDTPLS | 926 | Q9Y2H5 | |
| GKIQRPPEDSIQPYE | 76 | Q16851 | |
| VAPRFDVNAPDLYIP | 146 | Q5BJH7 | |
| LRPSPEDEAIYGPNT | 496 | Q9UDY2 | |
| HYGREESAEQVPPPA | 296 | Q05516 | |
| ARPQYPEIPLVDSDS | 126 | Q8N427 | |
| PYEARQPLVQPEGSS | 226 | Q8NFH8 | |
| EAIFPSPRELEGPVY | 691 | O43295 | |
| IVAYVDDLDRRGPPP | 1071 | O14776 | |
| VPDLPEGITVAYTIP | 361 | Q9GZZ9 | |
| EYLLPNIGRTVPPGD | 1121 | Q9P227 | |
| FPASYVQVIRAPEPG | 51 | Q96RF0 | |
| PDLGQVPEIDVPSYL | 236 | Q6VEQ5 | |
| VVPREVYPEETPELG | 71 | O75063 | |
| FYVPDLGQVPEIDVP | 246 | A8MWX3 | |
| LGQVPEIDVPSYLPD | 251 | A8MWX3 | |
| EIDVPSYLPDLPGIA | 256 | A8MWX3 | |
| ERGIPQDTIPEYPEL | 76 | Q96GC6 | |
| ENIFPSPRELEGPVY | 676 | O75044 | |
| DSPADPVERPIYLTN | 446 | Q92545 | |
| LDYLTAPNPPTIREE | 376 | O15344 | |
| PLQAETPGSAVDYPL | 3886 | P22105 | |
| YFEPPVEESALERRP | 61 | O95551 | |
| VSPSPLIYRPEAEET | 131 | Q6ZNK6 | |
| FYVPDLGQVPEIDVP | 231 | C4AMC7 | |
| LGQVPEIDVPSYLPD | 236 | C4AMC7 | |
| EIDVPSYLPDLPGIT | 241 | C4AMC7 | |
| NEYTEGPSVVKRPAP | 51 | O43609 | |
| LNYNPEDPPGSEVLR | 291 | Q15166 | |
| RVEDVPIPIYFPPES | 61 | Q13084 | |
| IARVPADPDYLPRTE | 251 | Q15569 | |
| AYLEVTDVIADRPPP | 441 | Q9Y6N7 | |
| IPPPLYTETGLEFQD | 121 | Q8N6L7 | |
| PEAPPSYRESIAGLV | 141 | Q8N6L7 | |
| VPRDVPPDTVGLYVF | 46 | Q6EMK4 | |
| TRYCEIPGPDLEESP | 41 | Q9UDY6 | |
| HVEVYRSGPEEPPSL | 106 | Q6NX49 | |
| AIYLLTDGRPDQPPE | 601 | Q502W6 | |
| YPEAPEELSRLGTPE | 176 | O60315 | |
| PDPDPVQELTYDLRS | 331 | Q9BZH6 | |
| PFPGYIDPDSLIVQD | 361 | Q8WY21 | |
| PNVPPTIYFGTRDER | 581 | Q14679 | |
| RREVAPPYQGADPIL | 311 | P19438 | |
| NREAEAYTGLSPPVP | 206 | O43164 | |
| YVPDLGQVPEIDVPS | 216 | Q9NQA3 | |
| GQVPEIDVPSYLPDL | 221 | Q9NQA3 | |
| PPRGEPVTVYRLEES | 1576 | Q96QT4 | |
| PGYREVVILEDPGLP | 671 | Q63HR2 | |
| PPPELEERDVAAYSA | 541 | P49815 | |
| PAEPTPGYEVGQRKR | 1781 | P49815 | |
| YVARNGEPEPTPVVN | 116 | P40222 | |
| YSEDNPTPGIVINRP | 76 | Q99538 | |
| ATIDLVIGYDPPSAP | 116 | Q9NZM1 | |
| EPPGYERTELTLSPE | 31 | P15173 | |
| PEPGPAYDLTFCEVR | 811 | P54296 | |
| QPGPPYDVRASEVRA | 801 | Q5VTT5 | |
| LEERRYPGEVTIPSP | 851 | Q9UL68 | |
| TPFQAGTPRYDVPID | 296 | Q9HD90 |